CN103429321B - Membrane separation device, the system and method utilizing this device and data management system and method - Google Patents

Membrane separation device, the system and method utilizing this device and data management system and method Download PDF

Info

Publication number
CN103429321B
CN103429321B CN201280012852.1A CN201280012852A CN103429321B CN 103429321 B CN103429321 B CN 103429321B CN 201280012852 A CN201280012852 A CN 201280012852A CN 103429321 B CN103429321 B CN 103429321B
Authority
CN
China
Prior art keywords
blood
container
film
internals
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201280012852.1A
Other languages
Chinese (zh)
Other versions
CN103429321A (en
Inventor
丹尼尔·R·博格斯
马克·J·布雷尔顿
本杰明·E·库斯特斯
闵庚伦
克里斯托弗·J·瓦格纳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fenwal Inc
Original Assignee
Fenwal Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fenwal Inc filed Critical Fenwal Inc
Publication of CN103429321A publication Critical patent/CN103429321A/en
Application granted granted Critical
Publication of CN103429321B publication Critical patent/CN103429321B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D61/00Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/14Ultrafiltration; Microfiltration
    • B01D61/18Apparatus therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/02Blood transfusion apparatus
    • A61M1/0272Apparatus for treatment of blood or blood constituents prior to or for conservation, e.g. freezing, drying or centrifuging
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/02Blood transfusion apparatus
    • A61M1/0281Apparatus for treatment of blood or blood constituents prior to transfusion, e.g. washing, filtering or thawing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/26Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes and internal elements which are moving
    • A61M1/262Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes and internal elements which are moving rotating
    • A61M1/265Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes and internal elements which are moving rotating inducing Taylor vortices
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3403Regulation parameters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/342Adding solutions to the blood, e.g. substitution solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3496Plasmapheresis; Leucopheresis; Lymphopheresis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3621Extra-corporeal blood circuits
    • A61M1/3622Extra-corporeal blood circuits with a cassette forming partially or totally the blood circuit
    • A61M1/36224Extra-corporeal blood circuits with a cassette forming partially or totally the blood circuit with sensing means or components thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3621Extra-corporeal blood circuits
    • A61M1/3622Extra-corporeal blood circuits with a cassette forming partially or totally the blood circuit
    • A61M1/36225Extra-corporeal blood circuits with a cassette forming partially or totally the blood circuit with blood pumping means or components thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3621Extra-corporeal blood circuits
    • A61M1/3622Extra-corporeal blood circuits with a cassette forming partially or totally the blood circuit
    • A61M1/36226Constructional details of cassettes, e.g. specific details on material or shape
    • A61M1/362262Details of incorporated reservoirs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3621Extra-corporeal blood circuits
    • A61M1/3622Extra-corporeal blood circuits with a cassette forming partially or totally the blood circuit
    • A61M1/36226Constructional details of cassettes, e.g. specific details on material or shape
    • A61M1/362263Details of incorporated filters
    • A61M1/362264Details of incorporated filters the filter being a blood filter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3621Extra-corporeal blood circuits
    • A61M1/3622Extra-corporeal blood circuits with a cassette forming partially or totally the blood circuit
    • A61M1/36226Constructional details of cassettes, e.g. specific details on material or shape
    • A61M1/362265Details of valves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3621Extra-corporeal blood circuits
    • A61M1/3622Extra-corporeal blood circuits with a cassette forming partially or totally the blood circuit
    • A61M1/36226Constructional details of cassettes, e.g. specific details on material or shape
    • A61M1/362266Means for adding solutions or substances to the blood
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3621Extra-corporeal blood circuits
    • A61M1/3627Degassing devices; Buffer reservoirs; Drip chambers; Blood filters
    • A61M1/3633Blood component filters, e.g. leukocyte filters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3687Chemical treatment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3692Washing or rinsing blood or blood constituents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/38Removing constituents from donor blood and storing or returning remainder to body, e.g. for transfusion
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D63/00Apparatus in general for separation processes using semi-permeable membranes
    • B01D63/06Tubular membrane modules
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D63/00Apparatus in general for separation processes using semi-permeable membranes
    • B01D63/16Rotary, reciprocated or vibrated modules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3621Extra-corporeal blood circuits
    • A61M1/3622Extra-corporeal blood circuits with a cassette forming partially or totally the blood circuit
    • A61M1/36222Details related to the interface between cassette and machine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/33Controlling, regulating or measuring
    • A61M2205/3331Pressure; Flow
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/50General characteristics of the apparatus with microprocessors or computers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/60General characteristics of the apparatus with identification means
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D2313/00Details relating to membrane modules or apparatus
    • B01D2313/08Flow guidance means within the module or the apparatus
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D2313/00Details relating to membrane modules or apparatus
    • B01D2313/20Specific housing
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D2313/00Details relating to membrane modules or apparatus
    • B01D2313/20Specific housing
    • B01D2313/205Specific housing characterised by the shape
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D2315/00Details relating to the membrane module operation
    • B01D2315/02Rotation or turning
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/40ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis

Abstract

Disclose a kind of membrane separation device for blood processing procedures.In one embodiment, provide rotation membrane separator, in the gap rotated between film and shell, wherein produce at least two district or region, make to reduce the gap rotating between film and shell to limit radial rib or the ridge of two fluid masses by relevant to rotating film, preventing the mixing of fluid between two regions, the fluid in two regions of this ridge isolation is to minimize the mixing between two regions.Disclose the automated systems and methods of selected blood constitutent for the unit previously collected whole blood being separated into the erythrocyte such as concentrated and blood plasma, for directly collecting erythrocyte and blood plasma from blood donor in one way and washing for cell.Also disclose data management system and method and loading method.

Description

Membrane separation device, the system and method utilizing this device and data management system and method
Cross-Reference to Related Applications
This application claims submit on March 11st, 2011 U.S. Provisional Application No. 61/451,903, The JIUYUE in the 61/537,856th, 2011 that JIUYUE in 2011 is submitted on the 22nd within 23rd, submit to the The interests of the applying date of the 61/550th, 516 submitted on October 24th, 61/538,558 and 2011, The entire content of each application is incorporated herein by.
Technical field
The application relates in part to utilize the segregation apparatus of the surface type relatively rotated, wherein At least one carry for the film from the filtering flow component passed through between the surfaces;The application Relate in part to include fluidic circuit and the system of this seperator;And the application part Be directed to use with this system and separate from whole blood, storage medium, suspension medium, the supernatant etc. Such as erythrocyte, blood plasma or the biological cell of leukocyte.
Background technology
Traditional blood collecting persistently depends heavily on by car of donating blood from healthy blood donor, logical Cross visit Blood Center or hospital etc. of blood donor and manually collect whole blood.At typical manual collection In, by make simply whole blood under gravity and venous pressure from the blood flow of blood donor to receipts Whole blood collected by collection container.The amount of the whole blood of extraction is typically about " unit " of 450ml.
More specifically, this collection generally uses the pre-assembled layout of pipeline and container or sack, Including for from the flexiplast Primary containers of blood donor recruiting unit whole blood or sack and one or Multiple " attached " containers or sack.Blood is primarily collected in Primary containers, and this mainly holds Device also accommodates anticoagulant and (generally comprises sodium citrate, phosphate and dextrose commonly referred to CPD).Preservative (commonly referred to " additive solution " or AS, and often comprising can be included Saline, adenine and glucose medium its be referred to as SAG) as after blood is collected The sack used in process and a part for the bigger assembly of pipe.
After collecting unit whole blood, common practice is to be utilized by this unit whole blood in blood bank (frequently referred to " backstage is tested to blood constitutent treatment of laboratory for the pipeline connected and container transport Room "), for processing further.Process further and typically require Primary containers and relevant pipe Road and attaching container are manually loaded into centrifuge so that whole blood to be separated into the erythrocyte such as concentrated Component with the blood plasma etc. rich in hematoblastic blood plasma or Platelet poor.This component is subsequently by hands The attaching container of other pre-connection is transported on dynamic ground from Primary containers, and can again be configured to by Centrifugation is out from blood plasma for platelet.Subsequently, blood constitutent can be carried out by filtering Remove leukocyte, in order to process further or storage.In a word, this process is time-consuming, laborious And it is subjected to personal error.
The another kind of everyday tasks performed by blood bank and blood Collection Center is " cell washing ".This can lead to Cross and remove less desirable cell or other material performs to remove and/or replaces what cell was suspended Liquid medium (or one part), with concentrate or further the cell in concentrated liquid medium and/ Or daf molecule suspension.
Cell washing system most typically ground in the past relates to the centrifugal, the supernatant of cell suspension Settling flux in new medium of decant, concentrating cells and these steps may repeat until outstanding The cell of liquid is in the highest or other desired concentration.In blood and blood constitutent process The centrifugal separator used generally is using in this cell washing process.
These processes are also the most time-consuming, need the most manually to handle blood or blood constitutent And the various fluid treating plant of assembly and disassembly.This most not only increases cost, Er Qiezeng Add the probability of personal error or mistake.Correspondingly, although blood separating mechanism and the number of technique Development in 10 years, but wish constantly be applicable to basic blood collecting and process the more preferable of mode And/or more effectively segregation apparatus, system and method.
Although many existing blood separation device and program are used for centrifugation principle, But there is the device of the another category of use based on film, it has been used to plasma depletion, i.e. Blood plasma is separated from whole blood.More specifically, this device utilizes the table relatively rotated Face, perforated membrane is carried at least one of which surface.Typically, this device utilizes outer stationary housings With the interior rotor covered by perforated membrane.
A kind of such known sizing device of dehematizing is by the Fenwal of the Lake Zurich of IIIinois, Inc. sellSeperator.The detailed description rotating membrane separator can be Authorizing United States Patent (USP) No.5 of Schoendorfer, find in 194,145, this patent is by quoting It is expressly incorporated herein.That patent describes the film with the internal gathering system being arranged in static housing The rotator covered.In annular space that blood is supplied between rotator and shell or gap. Blood moves along the longitudinal axis of shell towards leaving region, and blood plasma is through film and leaves shell and enters Enter to collect sack.Remaining blood constitutent (mainly erythrocyte, platelet and leukocyte) exists Move to an off open region between rotator and shell and be usually brought back to blood donor subsequently.
Have been found that and rotate the plasmapheresis speed that membrane separator provides excellent, this mainly due to Unique the flow pattern (" Taylor (Taylor) caused in the gap rotated between film and shell Whirlpool ").Taylor whirlpool contributes to preventing blood cell to be deposited on film and pollutes or blocking film.
Although rotating membrane separator to have been widely used in collection blood plasma, but they generally need not In collecting other blood constitutent, specifically erythrocyte.Rotate membrane separator to be generally also not used in Cell washs.One of the rotation membrane separator used in the most erythrocytic cell washs is shown Example is in United States Patent (USP) No.5, and described in 053,121, this patent is also by being incorporated herein by reference.So And, system described herein utilizes two associated in series or in parallel separation rotator to wash " outflow " blood of patient.Its of membrane separator is rotated for separate blood or blood constitutent It describes can also be in United States Patent (USP) No.5,376,263;No.4,776,964;No.4,753,729; No.5,135,667 and No.4,755,300 finds.
Subject matter disclosed herein provides the development further of membrane separator, possible cost reduces And it is better than various other development and advantages of existing manual blood collection and process.
Summary of the invention
This theme has many aspects that can use in various combinations, and one or more specifically The disclosure of embodiment is not intended to for the purpose of disclosure and description.This general introduction only highlights this master Several aspects of topic and other aspect are disclosed in accompanying drawing and description in further detail below.
Pass through the disclosure, it is provided that a kind of membrane separator, whole blood is more effectively separated into it by it Component and can advantageously in various blood processing systems and program use.
Specifically, it is provided that a kind of blood filter device, it has: the shell of generic cylindrical Body, it has inwall;And internals, it is arranged on the inside of housing and has outer surface. The inwall of housing and/or the outer surface of internals include with housing towards wall or internals It is spaced so that limiting the perforated membrane of annular gap, housing and internals betwixt is phase The most rotating.Provide for including that blood plasma and erythrocytic whole blood introduce annular gap Entrance, provide simultaneously for from annular gap guide remaining blood constitutent second outlet. The surface area of film be enough to so that the erythrocyte time of staying in annular gap is not enough to cause red The speed of the excessive hemolysis of blood cell takes separated plasma.In one embodiment, this is by providing There is the inside structure of the length bigger than the length of the internals of existing apparatus and diameter and/or diameter Part realizes.More specifically, include having for existing rotation film according to the internals of the application The length of the rotor of device is up to the length of 2.5 times and for rotor straight of existing rotation film device Footpath is up to the rotor of the diameter of 2.0 times.This seperator has been found to provide the blood plasma improved to divide From speed and also provide for preserving the acceptable low-level haemolysis in blood.A concrete reality Executing in mode, the length of internals is about 5.51'' and diameter is about 1.5''.
Also disclose a kind of method designing this membrane separation device.The method includes utilizing from existing The input development model obtained with having defecator semiempirical, described existing defecator has finger The perforated membrane of sizing specifies output to obtain.Model is applied to the imagination of the film of varying dimensions Defecator is to obtain predictive value for this appointment output.Check this predictive value, and based on finger The predictive value of fixed output relatively select filter membrane size.In an aspect, the method carries For improving the film surface area of one or more filtering features.In particular example, defecator bag Including internals, filter membrane is installed to this internals, and internals is mounted to relative to substantially Cylindrical housing into rotation, and the diameter of internals and/or film length allow in blood Erythrocyte does not has the filtration in the case of excessive dissolution.In the concrete application of model, internal structure Part has the diameter of the internals for existing defecator and is up to about the diameter of 2.0 times and/or is The film length of existing defecator is up to the film length of 2.5 times.
In another aspect of the present disclosure, it is provided that a kind of membrane separator, at this membrane separator In gap between internals and shell produces at least two district or region so that stop The mixing of fluid between the two regions.More specifically, it is provided that a kind of membrane separator, In this membrane separator, the inwall of external structure and/or the outer surface of inner structure include reducing two The radial rib in the gap between surface or ridge are to limit two fluid masses, and this ridge isolates Liang Ge district Fluid in territory is to minimize the mixing between two regions.
Accompanying drawing explanation
These and other feature of this theme describes in the following detailed description and shows in the accompanying drawings Go out, in the accompanying drawings:
Fig. 1 is to rotate the partial-section perspective view of membrane separator and be partly removed to illustrate carefully Joint.
Fig. 2 is the longitdinal cross-section diagram rotating membrane separator of Fig. 1.
Fig. 3 is based on Design Theory model, according to relative Filter length and rotator radius Outlet hematocrit and the isogram of outlet wall shear stress.
Fig. 4 be based on film tangential velocity be constant Design Theory model, according to relatively filtering The outlet hematocrit of length and rotator radius and the equivalence of outlet plasma hemoglobin concentration Line chart.
Fig. 5 is based on Design Theory model, according to relative Filter length and rotator radius Outlet hematocrit and the isogram of Taylor number.
Fig. 6 is based on Design Theory model, according to relative Filter length and rotator radius The graphics of plasma hemoglobin concentration.
Fig. 7 is the rotation film device according to the application or the perspective view of seperator.
Fig. 8 is the schematic cross section rotating membrane separator according to the application, wherein rotates Device includes for limiting the ridge radially extended separating fluid mass.
Fig. 9 is the signal for processing previously automatization's whole blood piece-rate system of the whole blood of collection Figure, it includes disposable fluidic circuit module and has the fluid assembled thereon and flow back The durable controller of road module or control module.
Figure 10 shows of the fluid flowing through fluidic circuit described herein The flow graph of embodiment, produces for unit whole blood is processed into Red Blood Cells Concentrate product and blood plasma Product.
Figure 11 is similar to Fig. 9, but is disposable fluidic circuit or module and durable control The more detailed view of the parts of device module.
Figure 12 is the schematic diagram of the alternative embodiments of the system according to the disclosure, and wherein this is The separation of the system whole blood for previously having collected.
Figure 12 A is analogous to the schematic diagram of another alternative embodiments of Figure 12.
Figure 13 is the saturating of such as two pump blood separation systems shown in Fig. 9,11,12 and 12A View.
Figure 14 is analogous to the schematic diagram of another alternative scheme of Figure 12, except including three pumps Outside, it is shown that the system in filled stage.
Figure 15 is the schematic diagram of the system of Figure 14, it is shown that the system in separation phase.
Figure 15 A is analogous to the schematic diagram of another alternative three pump system of Figure 14 and 15.
Figure 16 is the schematic diagram of the automatization's whole blood collection system according to the disclosure, it is shown that be used for The configuration of the system that automatization's chair limit is collected and in filling pattern from the place of whole blood of blood donor Reason.
Figure 17 is the schematic diagram of the system of Figure 16, it is shown that be used for collecting whole blood and being divided by whole blood Configuration from the system becoming erythrocyte and blood plasma.
Figure 18 is the schematic diagram of Figure 16, it is shown that for complete from blood donor collect blood it The configuration of the rear system utilizing anticoagulant rinse-system.
Figure 19 is the schematic diagram of the system of Figure 16, it is shown that at the end of blood collection procedure be The configuration of system.
Figure 20 is the schematic diagram of the system of Figure 16, it is shown that for by leukocyte filter mistake The configuration of system in the erythrocytic optional layout that filter is collected.
Figure 21 is the alternative embodiments of the automatization's whole blood collection system for Figure 16-20 Schematic diagram, the disposable fluid circuit parts being wherein intended for single use include as blood donor close to dress The integrated of a part of the extraction pipeline put removes leukocyte filter.
Figure 22 is the alternative embodiments of the disposable fluid circuit being intended for single use of Figure 21 Schematic diagram, wherein goes leukocyte filter to be positioned in the extraction pipeline in inlet point downstream, at this At inlet point, anticoagulant is introduced into whole blood.
Figure 23 show in the cleaning according to the cell of method disclosed herein useful once Property external member.
Figure 24 shows use in the cell according to alternative disclosed herein cleans Another embodiment of disposable external member.
Figure 25 shows device useful in the cell according to method disclosed herein cleans The embodiment of control panel.
Figure 26-28 is the flow chart of the step in cell cleaning method disclosed herein.
Figure 29 is the flow chart illustrating the data managing method according to the disclosure.
Figure 30 is the data management system according to the disclosure and collection container and process kit The schematic diagram of combination.
Figure 31 is the various steps illustrating and including the method for data management according to the disclosure Flow chart.
Detailed description of the invention
Described below rotate membrane separator and in various automated systems according to the disclosure The more detailed description used.Should be understood that below concrete apparatus and method, description is intended to example Property and not all may change or application exhaustive.Therefore, the scope of the present disclosure is not limit Property processed and it should be understood that comprise those skilled in the art it is contemplated that change and embodiment.
Turn to Fig. 1 and Fig. 2, it is shown that rotate film blood separation or fractionating system, usually refer to It is set to 10.Such system 10 is generally used for extracting from the whole blood obtained by single human blood donors Blood plasma.In order to easy to understand, illustrate only plasma separating unit and relevant driver element, but It is to should be understood that this seperator is formed to include collecting sack, additive (such as saline or ACD) Sack, return the part of disposable system of sack, pipeline etc., and also exist and be used for grasping Make relevant control and the instrument system of device.
The general cylindrical that system 10 includes being mounted concentrically around longitudinally perpendicular central axis Housing 12.Internals 14 is installed with central axis coaxial ground.Housing is relative with internals Ground is rotatable.In shown preferred implementation, housing is static and internals is The most rotatable turning rotator in cylindrical housing 12.The limit of blood flow paths Boundary is generally limited by the gap 16 between inner surface and the outer surface of turning rotator 14 of housing 12 Fixed.Interval between housing and rotator is sometimes referred to as shear gap.Typical shear gap can It is about 0.025-0.050 inch (0.067-0.127cm) and can have uniform size along axis, Such as, wherein the axis of rotator and housing is consistent.Such as, shear gap can also be week Variable to ground, the axis of its middle shell and rotator is skew.
Shear gap can also change in the axial direction, for example, it is preferred to increase in the flowing direction The gap width added is to limit haemolysis.This gap width can be at about 0.025 to about 0.075 English In the range of very little (0.06-0.19cm).Such as, housing can be consistent with the axis of rotor And the diameter of rotor above reduces and the diameter of the inner surface of housing at axial direction (flow direction) The diameter keeping constant or housing increases and root diameter keeps constant, or two surfaces exist Diametrically change.Such as, gap width can be about 0.035 at the upstream in gap or arrival end Inch (0.088cm) and the downstream in gap or destination county are about 0.059 inch (0.15cm). Gap width can be changed by internal diameter by the external diameter of change rotor and/or towards surface of shell. Gap width can the most point-blank or staged or change in some other way.No matter How, the width dimensions in gap is preferably selected such that and relatively rotates under speed desired, Taylor (Taylor)-Ku Aite (Couette) stream of such as Taylor whirlpool is produced in gap, And restriction haemolysis.
Whole blood is supplied from entry conductor 20 by ingate 22, and blood is directed to by ingate 22 Blood in the path tangent with the circumference of the upper end around rotator 14 flows into region In.In the bottom end of cylindrical housings 12, inner walls includes leaving hole 34.
Cylindrical housings 12 is by having the upper end cap 40 of lug bosses at end part 42 and terminating at and central shaft The bottom housing 44 in the plasma outlet port hole 46 that line is concentric completes, and the wall of upper end cap 40 is non magnetic 's.
Rotator 14 is rotatably installed between upper end cap 40 and bottom housing 44.Rotator 14 include centre arbor or the rotor 50 shaped, and its outer surface is configured to limit by toroidal zone 54 Separate a series of spaced apart circumferential groove or rib 52.The surface limited by circumferential groove 52 leads to Road is connected with each other by longitudinal fluting 56.At every end of mandrel 50, these grooves 56 with Centre bore or manifold 58 are connected.
In the illustrated embodiment, the surface of turning rotator 14 at least in part, and preferably Substantially or entirely covered by cylindrical porous film 62.Film 62 is generally of the mark of 0.6 micron Claim pore-size, but other pore-size can be alternatively used.Described herein clearly Film useful in washing method can be fiber nethike embrane, cast film, track etching-film or this area skill Other type of film known to art personnel.Such as, in one embodiment, film can have It is solidified with the polyester webs (matrix) of nylon particles thereon, thus produces the component of only some size The crooked route that will pass.In another embodiment, film can thin by such as Merlon (about 15 microns of thickness) plate is made.In this embodiment, hole (hole) can be more than upper Those of face description.Such as, hole may be about 3-5 micron.The size of hole can be set to The component (such as, platelet, microgranule etc.) allowing little shape is passed through, and desired cell (example As, leukocyte) it is collected.
Turning rotator is arranged in upper end cap to rotate around pin 64, and pin 64 is press-fitted in side Close in end cap 40 and be seated in the end cylinder 66 of the part forming turning rotator 14 Cylindrical bearing surface 65 in.Interior rotator or shell body can be by any suitable rotations Driving means or system rotate.As indicated, end cylinder 66 is by between rotator 14 The ring 68 of the magnetic material connecing driving surrounds partly.Driving motor 70 quilt outside housing 12 Couple so that the annular magnet drive member 72 of permanent magnet 74 rotates in including at least one pair of.With Endless drive 72 to rotate, the ring 68 within housing 12 and the magnet 74 of hull outside Between magnetic attract rotator 14 is locked onto peripheral driver, cause rotator 14 to rotate.
In the lower end of turning rotator 14, the end that central outlet aperture 58 is concentric with concentricity axis Centre-drilling hole 76 in bearing 78 is connected.End bearing base is by forming central opening 82 times The interior shoulder 80 at edge limits.Central opening 82 is connected with plasma outlet port hole 46.Such as shell Completely or partially being covered by film towards interior surface of body, then can be provided below fluid at film Collect or manifold is to collect blood plasma and to be conducted through housing outlets (not shown).
I. membrane separator designs
Consistent with the one side of the application, it is provided that a kind of rotation membrane separator, it provides improvement Plasmaflux, retain blood in there is the most low-level haemolysis.Known have respectively Plant the impact factor by the filtering traffic of rotation membrane separator, including velocity of rotation, rotate film And the effective area of the size in the gap between shell, film, erythrocyte (or hematocrit) Concentration and blood viscosity.Previous practice in the design rotating film device is mainly by warp Test, to a certain extent indefinite by the effect of the various design parameters about performance and haemolysis Phenomenon describe assisted.This has turned out in terms of the development time spent and technical resource It is invalid.
By contrast, the parameter rotating membrane separator of the application is based on considering the local through film The quantitative Differential Model of blood plasma speed and local hemoglobin concentration determines.These Differential Models In the length upper integral of device to provide total plasmaflux in device exit and blood plasma blood red Protein concentration.
The method includes based on existing Plasmacell-C seperator geometry and operating condition Operation input, including blood donor's hematocrit, access ports blood flow, velocity of rotation with have Effect membrane area.The factor also having is the geometry input of rotor radius, the width of annular gap and holds The length of row integration.See table 1 below.In order to obtain the predictive value assuming seperator, rotor Radius and Filter length are with 0.05 for increment from about the 1.0 of current Plasmacell-C value up to about 2 times are changed, and provide 21 × 21 design space grids for each output variable interested. For all devices, the housing tapering in exit and gap remained constant, and access space and turn Dynamic speed correspondingly changes.Also developed blood viscosity and density and hematocrit, temperature Model concentration dependent with anticoagulant.
Table 1
The input that model calculates
Parameter, unit Value
Access ports blood flow, ml/min 106
Entrance hematocrit, % 42
Temperature, DEG C 35
Citric acid salt concentration, % 5.66
Filter length, inch 2.992
There is the rotor radius of film, inch 0.5335
Access space, inch 0.0265
Outlet gap, inch 0.0230
Effective film mark 0.5
The width of film bond area, inch 0.18
Velocity of rotation, rpm 3600
Wall hematocrit, % 0.90
Erythrocyte radius, μm 2.75
Cell hemoglobin concentration, mg/dL 335.60
Plasma density, g/cm3 1.024
The erythrocyte density filled, g/cm3 1.096
The viscosity of citrate blood plasma, cP 1.39
In a kind of implementation of the method, long for rotor radius, velocity of rotation and integration The various values of degree obtain the output of plasmaflux and hemoglobin concentration.The result of model illustrates In outlet hematocrit and outlet wall shear stress (Fig. 3), outlet hematocrit and outlet Plasma hemoglobin concentration (Fig. 4) and outlet hematocrit and Taylor number (Fig. 5) in In superposition isogram, all of all become with relative Filter length and rotator radius.As This uses, and " Filter length " is understood to start the center to end from groove or rib 52 Mandrel or the axial length of rotor 50.It generally represents the length of the film that can be used for filtration." rotation Turn device radius " or " rotator diameter " be understood to be attached with radius or the diameter of the rotor of film. Fig. 6 shows the blood red egg of the blood plasma according to Filter length and rotator radius in three-dimensional curve White result, it is shown that hemoglobin increases with device and increases.These results the most evaluated with The optimum balance of the high plasmaflux with the most low-level haemolysis is provided.
This model shows, the effective area of film has the positive influences of maximum to performance.And, to the greatest extent Pipe increases membrane area and increases membrane area than by increasing rotor length by increasing root diameter Affect flow more energetically, but owing to the speed of the increase of film too increases the probability of haemolysis, And therefore increase the shearing force in gap.
Correspondingly, its use of model prediction also will have the most low-level haemolysis, general Cause length and the diameter of the rotor of the membrane area of increase.(result based on model) prototype is divided Disembark and manufactured and test, with checking by the result of model prediction.Table 2 below ought Before Plasmacell-C sizing device of dehematizing enter with two kinds of possible alternative schemes based on model Row contrast.
Table 2
Reference table 2 and Fig. 7, rotates membrane separator 10 and includes having rotator diameter D, filtration The turning rotator 14 of length FL and total length L OA.At such as Plasmacell-C seperator Typically dehematize in sizing device, rotor has the diameter D of about 1.1'', the Filter length of about 3'' Total length L OA of FL and about 5.0''.
According to the application, it has been found that the diameter of film can be increased up at sizing device of typically dehematizing About 2.0 times of the diameter of the film of middle discovery, and increasing length adds up at sizing device of typically dehematizing In about 2.5 times of length rotating film.Increase in these girth internal rotor sizes can increase Filter membrane area, be enough to provide high plasmaflux, provides the most low-level haemolysis simultaneously. In concrete example, can advantageously have the straight of 1.65'' according to the rotation membrane separator of the application Filter length FL of footpath D, 5.52'' and total length L OA of 7.7''.
With the blood of cattle and people, prototype is rotated membrane separator to test with checking by model prediction Result.The blood of 100ml/min is obtained with the rotator speed changed from 1000-3500rpm Flow quantity.Acquisition 80% and higher outlet hemocyte ratio before film experiences high-caliber pollution Appearance level.The acquisition time of 880ml blood plasma between about 18 minutes and 20 minutes in the range of.
As it has been described above, there is directly pass the erythrocytic time of staying in shear gap with haemolysis amount System.In rotating membrane separation device, there is flow region, Qi Zhongliu in the axial length along rotor Body flowing is relatively stagnated, and causes the bag of haemolysis.Reach the red blood from high haemolysis region The degree that ball is mutually mixed with the flowing in low haemolysis region, the erythrocytic quality deterioration of collection.
Correspondingly, keep consistent with the another aspect of the application, it is provided that do not using sealing member In the case of in the gap rotating membrane separator, produce the method for fluid flow region of separation. The flow region separated is reduced or minimized the shadow of the mixing of fluid between two flow regions Ring.The flow region separated by gap, have a bossed rib or ridge realizes reducing or Minimize the gap between rotator and exterior circular column.Preferably, ridge or rib are disposed therein rotation On rotor surface outside transferring film is attached.
Ridge is preferably positioned the border limiting HT flow region.The radial dimension of ridge with The mixability allowed between two regions thus limited is inversely proportional to, the bigger radial direction of ridge Size allows less mixing.The axial dimension of ridge or scope also become with the mixability allowed Inverse ratio, bigger axial dimension allows less mixing.The axial dimension of ridge is preferably at least One clearance ruler modest ability is to minimize the formation of the adjacent Taylor whirlpool causing less desirable mixing.
With reference to Fig. 8, it is shown that the schematic cross section rotating membrane separation device 10 is shown.Device Including the exterior circular column 12 fixed and the rotation inner cylinder with the filter member carried on it 14.According to the application, it is provided that have the inner cylinder of radial ridges 90.This ridge will be for rotating Gap 16 between device and shell body is divided into two fluid masses.First fluid region 92 has The region of stagnation, non-perfusing of flowing, is typically extending beyond the rotator of filter membrane In part.The generally second fluid region 94 of contact filtration film has the HT region of flowing.
Because first fluid region 92 does not irrigates, so resting on blood ratio therein at second The shear stress that blood in body region 94 is exposed to increase continues the longer time period.Therefore, Blood in first fluid region 92 can generally become haemolysis occurs and has high free blood red Albumen (Hb) concentration.Ridge 90 suppresses the fluid between two fluid masses to flow, thus minimum The blood Hb blood low with second area 94 that Hb in change first area 92 pollutes mixes Degree.
Although it is one that ridge 90 is shown as with rotor, it can also be formed at the interior of exterior circular column To realize same effect on side.As mentioned above, the axial dimension of ridge should be at least one Gap size is long.It is generally of in rotation for performing plasmapheretic typical rotation membrane separation device The gap of the 0.023'' to 0.0265'' between device and containing wall, and can have according to the ridge of the application There is the axial dimension in same general scope.But, the larger axis of ridge will cause subtracting to size Little mixing, and in one example, it has been found that the radial direction of the axial dimension with 0.092'' is prolonged The rotor of the ridge stretched is effective.
II. for processing the system and method for the previously whole blood of collection
Above-mentioned rotate that membrane separation device can be advantageously utilised in that existing apparatus is often unsuitable for each In kind of blood processing system and method, especially for obtain erythrocytic system and during. In a type of system and method, the whole blood that rotator may be used for previously having collected " after Platform laboratory " process, as shown in Fig. 9-15A.
Turn now to Fig. 9, it is schematically shown disposable fluidic circuit or modules A and joined Be set to coordinate with the flowing through flow circuits A and control the flowing through fluid circuit A can The durable controller re-used or module B.Disposable fluid circuit A shown in Fig. 9 include by The interconnective various parts of flexible plastic tube of the flow path between restriction parts.Loop The most pre-assembled and pre-sterilization, may be except whole blood reservoir and cell preservative agent container Outside unit.More specifically, the disposable loop shown in Fig. 9 includes whole blood reservoir 101, thin Born of the same parents' antiseptic solution container 102, blood constitutent seperator 108, plasma collection container 112, appoint That selects removes leukocyte filter 113 and red blood cell collection container 115.Although the most not showing Go out, but module B that can re-use can have with for support any or all container 101, 102, the suspension bracket of the associated weight scale of 112 and 115.Implement at various other discussed herein In mode, this suspension bracket/weight scale is likely not to have and is illustrated it should be understood that described A part for system.
Whole blood collection vessel 101 can be any suitable container, but before being usually wherein Have collected flexible plastic pouch or the sack of about 450ml whole blood.Container 101 can received It is a part for piece-rate system during collection and is subsequently joined to remainder or the reality of fluid circuit A It is a part of loop A when collecting on border.When collecting, according to usual program, by whole blood Mix to prevent premature set with the anticoagulant being positioned in Primary containers.Correspondingly, use herein " whole blood " include the blood that mixes with anticoagulant.
Flexible plastic tube 105 is attached to whole blood collection vessel, is such as filled by the connection of sterilization Put or other suitable attachment means, and whole blood reservoir 101 and with cell preservative solution conduit Whole blood fluid flow path, cell preservative solution line 103 is limited between the attachment in road 103 Flow path attachment is extended to from cell preservative solution container 102.Whole blood flow path and Flow path sections bracing with connective positional between all preservative flow paths is at entrance fixture 116.From This attachment, flow path extends to the ingress port in seperator 108 by pipeline 107.
As shown in Fig. 9 of description, seperator housing has the gap between housing and rotor That be connected and with for from seperator gap extract out concentrate erythrocytic Red Blood Cells Concentrate flowing The outlet that path conduits 110 is connected.Additionally, housing include from rotor with deviate from gap Film side (such as, internal rotor) be connected and be connected with plasma flow path conduits 111 Outlet.
In order to reduce the amount of leukocyte that may be present in erythrocyte, disposable fluidic circuit A optionally includes leukocyte filter 113, and it could be for causing the most exceedingly red Cell haemolysis or minimizing are collected in product and are removed from Red Blood Cells Concentrate in the case of erythrocyte number Any suitable well-known structure of leukocyte.Concentrate erythrocyte through concentrate red carefully The continuation 114 of born of the same parents' flow path from going leukocyte filter 113 to flow to storage container 15, This storage container can be any suitable plastic material compatible with erythrocyte storage.
As shown in Figure 9 schematically can re-use or lasting controller module B preferably Including the whole blood flowed from whole blood reservoir 101 for detection and the hematocrit of hematocrit Sensor 104.Hematocrit detector can be any suitable design or structure, but excellent Selection of land is as in United States Patent (USP) No.6, and described in 419,822, this patent is accordingly by being incorporated by Herein.
The lasting controller re-used or control module B also include entrance fixture 116, its Can be operated to control from whole blood reservoir 101 or the fluid of cell preservative agent container 102, Or optionally, simultaneously or proportionally from the fluid of both containers 101 and 102.For Controlling blood flowing in seperator, the module that can re-use includes inlet pump 106, and it is also Can be any suitable structure, and for example, it may be by little by little compressing or extruding formation The peristaltic-type pump that enters the pipeline 107 of the inlet flow paths in seperator and operate, flexible every Membrane pump or other suitable pump.Between pressure transducer 117 and pump 106 and seperator 108 Inlet flow paths is connected to determine inlet pump pressurization pressure.Sensor can export control system Unite under overpressure condition or under undervoltage condition or in the case of both, to provide warning function.
For controlling the flow of the Red Blood Cells Concentrate from seperator 108, the module that can re-use is also Including be associated with outlet flow path 110 and by with about inlet pump 106 description in the way of class As the outlet pump 109 that works of mode.Outlet pump 109 can also be any suitable structure, Such as peristaltic pump, flexible partition or other suitable pump structure.Leave the blood plasma stream of seperator Dynamic path 111 is not the most by pump control, and the volume flow passing plasma flow path conduits is From the inlet volumetric flow of pump 106 with from the difference between the exit volume flow of pump 109. But, module B that can re-use could be included for controlling blood plasma through plasma flow path The fixture 118 of the flowing of pipeline 111.
Disposable module A can also include and the blood plasma separated by seperator 108 for reception The plasma collection container 112 of plasma flow path fluid communication.Because blood plasma passes seperator 108 In perforated membrane, so the blood plasma being collected in container 112 is mainly cell-free plasma and permissible It is adapted for being given to patient, frost storage or subsequent treatment.
Figure 10 generally illustrates one or more flowing roads of the fluid through the system shown in Fig. 9 Footpath.Specifically, it illustrates whole blood from single unit whole blood reservoir 101 through whole blood hemocyte Specific volume detector 104 flow to the attachment being positioned in the flow path at binary fixture 116. Cell preservative agent solution, such as red blood cell preservative solution, also flow from plasma container 102 Attachment at binary fixture 116.According to processing stage, binary fixture allows whole blood or thin Born of the same parents' preservative flows downstream to the remainder of system.Optionally, fixture 116 can be ratio Example fixture flows with the whole blood and red blood cell preservative allowing selected ratio simultaneously.
Flow through inlet pump 106 from binary fixture 116, whole blood or cell preservative fluid to flow To segregation apparatus 108.As explained before, segregation apparatus utilizes the housing turned opposite to and turns Son, at least one of which carries the film allowing blood plasma to pass through.In one embodiment, film is taken Band is on the surface of rotor and blood plasma is through this film and through the inner gateway labyrinth in rotor, finally Leave and arrive plasma collection container 112.When film is arranged on rotor, device commonly referred to rotation Transferring film seperator, as shown in Figure 10.It should be appreciated, however, that film can be arranged on shell possibly On the inner surface of body, the gap between the inner surface and the outer surface of film of housing wall, or Film can carry and on the inner surface of rotor and outer surface and housing, blood plasma be flow through simultaneously Film, it is thus possible to ground increases separating rate or the performance of seperator 108.From seperator 108, dense The erythrocyte of contracting flows through the housing outlets being connected with the gap between rotor and housing and through red Cell flow path 110 and outlet pump 109, it controls the erythrocytic volume flow concentrated.
Although can change from the hematocrit of the Red Blood Cells Concentrate of seperator 108 removal, but It is to expect that the hematocrit of Red Blood Cells Concentrate would be about 80-85%.Outlet pump 109 is by concentration Rbc pump is delivered in red blood cell collection container 115, and optionally through being positioned at pump 109 and receiving Collection container 115 between red blood cell flow path in remove leukocyte filter.Pump promotes and concentrates Erythrocyte go through the power of leukocyte filter and contribute to the process time is maintained rational model In enclosing, such as with the erythrocyte concentrated to manually set the gravity stream going through leukocyte filter The dynamic required time is compared.
The blood plasma (as shown in Figure 10) separated by seperator 108 flows from seperator device, example As from the outlet being connected with the labyrinth of the path in rotor, through single control fixture 118 also It flow to plasma collection container 112.As previously mentioned, because blood plasma is through film, so its base There is no cell on Ben and be suitable for being then supplied to patient, freeze and/or for processing, the most logical Cross fractional distillation and obtain the plasma component for other treatment product.If necessary, system is also Can include filter, such as in plasma flow pipeline 111, remove leukocyte filter.
Figure 11 illustrates and utilizes disposable fluid circuit modules A and that can re-use or lasting control A kind of pattern of the possible system of both device modules B.While shown as assemble, but stream Body loop modules A and lasting module B have separation and independent function and can also be with it Its system is used together.As in Figure 11 it can be seen that, disposable module A is conveniently mounted to On the face of module B that can re-use, module B that can re-use has relevant suspension bracket or support, Some of them can be associated with weight scale, for supporting the various containers of disposable system. As represented before, disposable module is preferably preassembled and pre-sterilization.Cell preservative is molten Liquid container can be as a part of pre-attached of disposable system or can increase after a while, such as By sterilization attachment means or other suitable attachment means.Comprise the unit whole blood of previously collection Whole blood reservoir can also be pre-attached to pre-assembled fluid circuit or by means of sterilization connect dress Put or other suitable attachment means is attached.
In this embodiment, the face of module B that can re-use includes for controlling cell preservative Agent solution is from the separation solution fixture 116a of the flowing of solution container 102, and it hangs on rising Solution support column.Whole blood reservoir 101 hangs on weight scale.Weight scale can be conventional Structure and can provide and can make to retain in a reservoir for sensing by the control system of module B The amount of whole blood and/or the weight measurement signals of the amount of whole blood processed by system.Once Sexual system includes extending through hematocrit detector 104 and through for controlling from whole blood reservoir Whole blood processed from container to the red blood cell flow path of the separation whole blood fixture 116b of flowing in system 105.Cell preservative solution flow path 103 and whole blood flow path 105 group at attachment Close, such as at v position or the y position of inlet pump 106 upstream end.The flow path of combination prolongs Extend through inlet pump and extend to the entrance on seperator device 108.As shown in Figure 11, Module B that can re-use includes driver element, is such as used for causing rotor to turn at seperator housing Dynamic extend through the magnetic drive unit of housing without drive member or component physical.? In this layout, rotor includes being turned by the magnetic drive unit being associated with the module that can re-use The driving element that dynamic magnetic couples.This system is authorizing United States Patent (USP) No. of Schoendrofer Being more fully described in 5,194,145, this patent is incorporated herein by.
The Red Blood Cells Concentrate outlet of seperator 108 is attached to extend through outlet pump 109 and extend To the red blood cell flow path 110 entering the optional entrance gone in leukocyte filter 113.Position Filter medium between the entrance and exit removing leukocyte filter substantially by leukocyte from red Cell is removed.From filter outlet, erythrocyte is carried by red blood cell flow path conduits 114 In red blood cell collection container 115.
Blood plasma controls fixture 118 from the plasma outlet port of seperator through plasma flow and is directed into blood Slurry is collected in container 112.In the way of similar with whole blood reservoir, Red Blood Cells Concentrate container 115 Hanging from weight scale with blood plasma container 112, it can be with module B that persistently maybe can re-use Control system carry out electronic communication with provide about concentrate erythrocyte and/or from whole blood collection The amount of blood plasma or the information of collection rate.
Although this system has shown that have some basic element of character above-mentioned and feature, but this description It is not meant to get rid of the interpolation of other parts, sensor the most as required, pump, filter etc.. For example, it may be possible to optionally wish filtered plasma or province before blood plasma enters plasma collection container Slightly remove leukocyte filter for erythrocytic.Although the blood plasma removed from seperator 108 is basic On there is no a cell, but may be further desirable to due to supply subsequently or process reason and filter Blood plasma.This description expection is not excluded for may adding or above-mentioned one or more of other parts The deletion of parts.
Turning now to the process of whole blood in shown system, separation process starts with filling system." fill out Dress " method that refers to prepare (that is, moistening) filter membrane before the use.Fluid moistening is utilized to have Help the sky during displacement is present in the substrate of film before the fluid causing pressure flows through film Gas.Generally, low viscosity non-biological fluid, such as cell preservative agent solution (solution of red blood cells, Such as,Solution) it is used for moistening to allow the displacement of maximally effective air.During loading, Fluid is removed until solution line from cell preservative solution sack 102 by inlet pump 106 103, whole blood pipeline 105, entrance pipe 107 and rotation film device 108 are fully filled with solution. For guaranteeing correctly to load, inlet pump 106 can move during loading clockwise and anticlockwise. Solution load purpose be by set up solution-blood interface prevent formed air-blood interface with And the film in moistening segregation apparatus.Each of which is to reduce the measure that erythrocytic haemolysis is taked.
After system successfully loads, closing cell's solution will be carried out by inlet pump 116 and flow Path 103.Shown entrance fixture be can with closing cell's antiseptic solution flow path 103 or The binary fixture of whole blood flow path 107.Then whole blood is passed whole blood flow by inlet pump 106 Path 105 and inlet flow paths 107 are pumped in seperator 108.The stream of inlet pump 106 Amount can export according to the expected product for specific program and change to 150 from about 10ml/min ml/min.Along with whole blood leaves whole blood reservoir 101, it will be through will be by IR LED reflection rate Measure the whole blood hematocrit detector 104 of the assessment producing whole blood hematocrit.Hemocyte The details of specific volume detector is at United States Patent (USP) No.6,419,822(title: be used for sensing hemocyte The system and method for specific volume) in explained, it is incorporated herein by.Whole blood hemocyte Bulking value is required for the initial control algolithm of shown system, but in other systems may Dispensable.
After whole blood has been filled with seperator 108, system will start to extract blood plasma from seperator, Seperator is separated into Red Blood Cell Concentrate and the most acellular by entering the whole blood rotating film device Blood plasma.To be worn by outlet pump 109 with the erythrocyte of the filling of the hematocrit of about 80-85% Cross outside red blood cell flow path 110 is pumped into seperator 108 and enter erythrocyte leukocyte mistake In filter 113.Outlet pump forces the erythrocyte of filling through erythrocyte leukocyte filter 113 And leave erythrocyte leukocyte filter 113 through red blood cell tube 114 and enter erythrocyte product Red Blood Cell Concentrate in product sack 115 will successfully be got rid of leukocyte and be also excluded from platelet. Whole blood automatic partition can also be completed in the case of not using erythrocyte leukocyte filter 113 From.In this case, erythrocyte leukocyte filter 114 will remove from system and erythrocyte produces Product 115 will not be excluded leukocyte or platelet.
In whole program, blood plasma is by with equal to the flow of inlet pump 106 and outlet pump 109 The flow of the difference between flow flows in blood plasma sack 113, such as mesh through plasma flow path 111 Before be similar to by Fenwal, Inc. sellOther rotation of application in instrument Transferring film separation application completes.The pressure at the film two ends produced by the skew in flow is by pressure Force transducer 117 is monitored.Pressure measxurement is for utilizing the U.S. submitted on April 27th, 2011 Patent application serial number 13/095,633(title: SYSTEMS AND METHODS OF CONTROLLING FOULING DURING A FILTRATION PROCEDURE) in The algorithm described controls plasmaflux, and this patent is incorporated herein by.
System in Fig. 9-11 separates the erythrocyte filled and blood plasma until whole blood sack by continuing 101 detect it is empty by passing air through whole blood hematocrit detector 104.Herein, Whole blood pipeline 105 will be closed and cell preservative solution line will by inlet pump 116 open with Start solution rinsing or rinse.During solution rinses, antiseptic solution will be by inlet pump 106 Remove and be pumped into from solution sack 102 in seperator 108.Plasma flow path 111 is at solution Closed by blood plasma fixture 118 during flushing.Solution rinses for by any blood remaining in system Liquid is flushed in erythrocyte product container 115.Solution rinses also by erythrocyte product container 115 Volume increase to suitable erythrocyte and store desired level.After solution flushing terminates, Complete the separation of unit whole blood.
Turn to Figure 12, it is shown that alternative two-pump system additionally.This embodiment is different from Fig. 9 essentially consists in the fluid from erythrocyte antiseptic solution at erythrocyte in place of embodiment It is added after whole blood separates.More specifically, accommodate the whole blood previously collected (preferably Ground with anticoagulant combine) container/sack 101 by leading to the pipe of blood separator 108 Road sections 107 is connected to disposable system A.Pump 106 coordinates with pipeline 107 with by whole blood pump Deliver to seperator 108.The container 102 accommodating erythrocyte preservative additive solution passes through pipeline 114 are connected to for the erythrocytic collection container 115 separated, and the erythrocyte of separation is also by this Pipeline 114 is directed to container 115 through leukocyte filter 114.
Container 101,102 is connected with the sterilization of disposable system can be complete by multiple different modes Become.Container 102 for additive solution can be as the part supply of disposable system A And can be sterilized at the remainder of disposable (pass through, such as, mist heat treatment) The remainder of disposable it is joined to (by such as gamma during final packaging afterwards Or after electron beam treatment carries out disinfection).Alternately, container 102 can be with disposable Remainder be integrally formed.In other alternative scheme, container 102 and whole blood reservoir Can separate with the remainder of disposable both 101 and in use by such as sterilizing Nail connecting portion 170(Figure 10 schematically shows) connect.This nail connecting portion preferably includes The filter of 0.2 micron is to maintain sterilization.
In another aspect preferably, additive solution container 102 is connected to white blood The pipeline 103 of ball filter 62 can also be matingly engaged by pump 109.Specifically, pump 109 Can flow for the erythrocyte making additive solution with leave seperator 108 with based on pipeline The double pump head of the flow of the internal diameter control of 103 and 110 each.
The embodiment of Figure 12 also uses other pressure transducer 117b and makes clear one's meaning and position to monitor The back pressure of blood cell filter 113.If back pressure becomes excess, such as the situation inaccessible at filter Under, sensor will work to control flow to guarantee that disposable will not be owing to crossing piezometric Power and rupture.
III. film loads
Consistent with another aspect of the present disclosure, it is provided that for the method loading film filter, to borrow Help the surface area of the method more likely maximum moistening filter membrane, thus maximize filtration/separation Available membrane area.Specifically, when loading rotation film filter system as described above, Wherein rotating membrane orienting to become to make pivot center perpendicular, Wetting Solution enters rotating separation The top inlet port of machine, and gravity is towards the outlet pull fluid at place bottom seperator.At this In the case of Zhong, formation may be moved through film surface by surface tension unevenly that load fluid Thus produce the air-fluid interface of division.Result is that some area of filter membrane is during loading May be not wetted, thus increase the probability that air is entrained in membrane matrix.The non-moistening of film Region subsequently become unavailable for separate, negatively affect membrane separation efficiency, until produce Enough pressure carrys out displaced air.
Correspondingly, it is provided that for the method loading membrane separator, it is by carrying during loading The more uniformly wetting film surface for air-fluid interface evenly.To this end, load fluid quilt It is made to advance through the surface of film in upward direction along with fluid-air interface in introducing seperator And resist gravity and work.This evenly moistening contributing to guaranteeing film, because during loading The air of displacement can move in a single direction and not advance along with air-fluid interface passes film And be entrained.
Therefore, according to this for the alternative method loaded, load fluid and be passed through bottom seperator Place port and be introduced in seperator.Load solution in seperator housing, resist gravity and to Upper advance is with the surface of wetting film, and air passes the port at seperator top from seperator simultaneously Discharge.Although " bottom is to top " description under the background rotating membrane separator should be filled in, but It is that it is equally applicable to need any kind of membrane separator that fluid loads before use.
With reference to Fig. 9 and 12, seperator 108 is vertically oriented so that membrane separator and housing enclose Rotatable relative to one another around the axis of less perpendicular, have at seperator top for connecing Receive the port of blood and the RBC of separation and passed end is left at blood plasma place bottom seperator Mouthful.Thus, according to a kind of mode for performing this alternative loading method, and with reference to Fig. 1 With 2, load solution can through rotate membrane separator 10 leave hole 34 or plasma outlet port hole One of 46 are introduced into, and air is discharged by ingate 22 simultaneously.Alternative according to being used for performing this The another way of loading method, seperator 10 can be squeezed or overturn for loading, Make to leave hole 34 and plasma outlet port hole 46 to be at the top of seperator 10, and ingate 22 At the bottom of seperator 10.Solution is loaded, simultaneously it is then possible to introduce through entrance 22 Fluid-air interface boost and air by leave one of hole 34 and plasma outlet port hole 46 or Both are discharged.After loading, seperator 10 is returned to its initial orientation, ingate 22 At top and leave hole 34 and plasma outlet port hole 46 in bottom.
It is another that Figure 12 A shows that " bottom is to the top " of above-mentioned blood separator 108 loads Outer alternative scheme.Compared with Figure 12, the entrance pipe 107 for whole blood is connected to separate The lower port (the embodiment middle outlet pipeline 110 at Figure 12 is already attached to) of machine 108, And export pipeline 110 is connected to the port (embodiment party at Figure 12 at seperator 108 top In formula, entrance pipe 107 is already attached to).In order to load the system of Figure 12 A, open folder Tool 116B and startup pump 106 are so that whole blood (being preferably added with anticoagulant) is through entrance pipe 107 ports passing it through housing lower end enter seperator 108.Along with whole blood fills seperator Housing, air is discharged through top-portion apertures, to substantially eliminate all air from device, and Filter membrane is wetted.
Complete load after, system continue operate as illustrated in fig. 12 with whole blood is separated into by Receive the blood plasma in container 112 and the erythrocyte being received in container 115.At separable programming At the end of, it is possible to use seperator is rinsed by the additive solution from container 102.
Turn to Figure 14 and 15, it is shown that according to the other alternative blood separation of the disclosure System.The system of Figure 14 and 15 is similar with the system of Fig. 9,11 and 12, except lasting module B Including for optionally making additive solution flow to (as shown in figure 14) during filled stage Seperator 108 or make (shown in Figure 15) during separation phase additive flow to separate Outside erythrocytic 3rd pump 119.The system of Figure 14 and 15 also includes for optionally permitting Permitted or anti-fluid flow (erythrocyte of separation and additive solution) is through leukocyte filter 113 Enter the other fixture 120 of red blood cell container 115.Before loading, fixture 120 can letter Singly stay open and pump 109 can pump the residual sky from container 115 and filter 113 Gas, minimizes the amount of the air being retained in container 115 when EP (end of program).With Figure 12 A class Seemingly, the system of Figure 14 and 15 utilizes the bottom of seperator 108 to top loading, uses except using Outside the additive solution loading fluid replaces whole blood.During the filling of system, such as Figure 14 Shown in, the air from disposable system A is pushed to whole blood reservoir 101.
During separation phase, system operates as shown in figure 15.At the end of separation phase, Additive solution is pumped into shown in seperator 108(filled stage as shown in Figure 14) To rinse seperator.
Turn to Figure 15 A, it is shown that alternative system additionally.The system of Figure 15 A and Figure 14 It is that the part B that can re-use includes three pumps 106,109 with the similar part of the system of 15 With 119.But, the system of Figure 15 A is for entirely with the similar part of the system of Figure 12 A The entrance pipe 107 of blood is connected to the port at place bottom seperator 108, and red for separate The export pipeline of blood cell is connected to the port at seperator top.Thus, the system of Figure 15 A with The system of Figure 12 A is similar to, and uses whole blood to load system.
IV. data management system and method
System disclosed herein may also include data management solutions.The weight scale of system and Add label printing device and permission user is directly obtained product from piece-rate system when program completes Weight label.This eliminates manually weighing and the data record used in currently processed method. Module B can include suitable user interface, such as touch screen, keypad or keyboard and sweep Retouch instrument, to allow user to input such as user blood donor identifier, blood bank identification, fluid circuit The information of kit number, lot number etc., this can improve the data management effect of blood manufacturing center Rate.
More specifically, and according to another aspect of the present disclosure, it is provided that one is used for making and whole blood Collect the relevant data of container and other relevant information is delivered to the later separation for whole blood Treatment loop and the one or more of one or more blood constitutents for this separation finally deposit Storage container automated method.The method schematically shows in the flow chart of Figure 29, wherein Thering is provided source container (step 122), it generally accommodates the unit whole blood previously collected, but source holds The blood products of the pre-treatment that device can accommodate.Source container is generally of relative about offering The identity of blood person and the data in acquisition time, place etc., such data are preferably machine can Read form, such as bar code or RFID label tag.These data are retrieved subsequently and transmit (step 124) and subsequently with treatment loop and final storage container it is associated (step 126).
Turn to Figure 30, it is shown that the one according to the use of the data management system of the present invention may System.Provide blood collection container 128 and there are three final storage containers 132,134 With 136 separating treatment loop 130.During whole blood collection, blood donor's identity information is encoded And be associated with the container of the whole blood for collecting.This can be by the bar code by blood donor id Label is manually placed on containers labels, container pin or pipeline and completes.It can also pass through RFID writer is utilized, by blood donor ID from collecting scale or hand-held device biography at collection time The RFID label tag being delivered to be attached to collect container completes.The use of RFID allows management bigger The information of amount, including such as Container Type, expiration date, acquisition time, collected volume, protects The data at scholar's identity, collection position etc..
Collect container 128 and process between kit 130/ storage container 132,134,136 Automation data transmission can collect container 128 sterilization be connected to process kit 130 In the environment of occur.It is, for example possible to use complete whole blood collection vessel to processing kit The Mechatronic Systems that sterilization connects.This system is respectively at December in 2011 21 days and 2012 The U.S. Provisional Patent Application Serial No. 61/578,690 and 61/585,467 that on January 11, in submits to Disclosed in, the two patent is incorporated herein by.Sterilization attachment means can be independent, Shown in provisional application as mentioned-above, or can be with the above-mentioned mould re-used Block B phase is integrated.Alternately, data management system can be simple with module B that can re-use Be associated, and there is no sterilization attachment means associated there.In any case, sterilization connects The module that device maybe can re-use includes being configured to automatically carry out or point out user to perform data The Programmable Logic Controller of the various steps of management method, as described in more detail below.
Data management system 138 includes processing unit, (such as carries for providing a user with information Show and confirm) screen 140, allow user's input information touch pad 142 and for collect Retrieve and transmit the scanner/reader of information between container 128 and process kit 130 144.System 138 also provide for bar coded sticker print or to process kit and be associated One or more RFID label tag transmission data.Turn now to Figure 31, it is shown that be generally illustrated data The flow chart of management method.Method includes collection sack and processes kit be loaded into can be again The module used and/or sterilization attachment means (step 140).Retrieve relevant to processing kit The data joined and the data (step 142 and 144) being associated with collection container.As being appreciated that , the order that these steps perform is not crucial.As mentioned above, these data can be adopted Take the form of bar code, RFID label tag or other form, process kit and relevant receipts thereof Collection container has the related data from relative collection container.This can take type slug Shape code label or write the form (step 146 and 148) of data to RFID label tag.Collect container Being connected with processing kit, preferably in sterilization linker (step 150), this is even The time during the order that above-mentioned steps performs that is connected on occurs.
The blood (step 152) in container is collected with post processing.Afterwards for collecting container data Retrieve and check process kit/storage container information (step 154 and 156).In this inspection Afterwards, storage container can be disconnected (step 158) from collecting container.
The system supplymentary user of the disclosure performs above-mentioned steps, wherein provides the prompting of various step And confirmation.Such as, if identification information is the form of bar code, then system prompts user scanning Process the bar code ID of kit and collect the blood donor ID of container.System will print subsequently Print copy bar coded sticker on machine, this printer for entirety or is attached to system with system, Type and the quality of label is determined by the type processing kit loaded simultaneously.System is then Bar coded sticker is applied to final storage container by prompting user.In system, blood treatment is become it After component, system prompts user scans final component containers bar code ID so that system is permissible Storage container was being checked correct bar shaped before collection container and process kit disassemble Code information.
If the information of identification is relevant with RFID label tag, then system automatically scans on collection container RFID label tag and subsequently automatically read the letter being included on the RFID processed on kit Breath.Collection information of container is the most automatically copied to and processes kit storage container by system The one or more RFID label tag being associated.After blood treatment is divided by system in groups, according to The type processing kit detected by instrument, system will read in final component containers RFID label tag is to allow taking blood storage container apart it from processing kit with collection container This identification information of front inspection.
Bar code and RFID can be utilized as redundant system in view of system, and include The above-mentioned some or all of steps being suitable for.Although barcode scanner/RFID reader is described For being associated with module B that can re-use, but its can be physically with datatron from status From special station, although being linked by data management software.
Although it is complete already in connection with collecting in the container separated with process kit and storage container Blood describes this data managing method, but it is equally about wherein collecting container and process Kit and the integral system of storage container or kit thereof use.And, the method May be used for about directly from the process of the whole blood of blood donor's extraction, as described herein below, wherein Blood donor's identity data is provided rather than collects container by blood donor, or at cell washing procedure In, identity data is associated with source container.
V. process the system and method for the whole blood from blood donor
According to another aspect of the present disclosure, above-mentioned rotation membrane separator can advantageously but step Rapid or " chair limit " collects whole blood and whole blood is separated in blood constitutent use.As described herein below , it is provided that with from blood donor collect whole blood simultaneously whole blood is separated into single unit red carefully Automatization's whole blood collection system of born of the same parents and blood plasma.System expection be one way collection system rather than Infusion returns to the blood donor of blood constitutent again.System preferably includes disposable fluidic circuit And dock and control the lasting control re-used of the fluid flowing passed through with this loop Device.The disposable fluidic circuit of pre-sterilization that flow circuits is preferably intended for single use, it is excellent Selection of land includes erythrocyte and plasma collection container, anticoagulant and erythrocyte additive solution, separation Machine and for for from blood donor whole blood enter fluid circuit provide path fistula.Lasting Controller preferably include microprocessor control electromechanical device, have be configured to control through The valve of the flowing in loop, pump and sense mechanism, and be suitable for the safety of whole blood collection program System and warning function.
The blood collection methods utilizing this system includes carrying out venipuncture and future for blood donor Be pumped in disposable loop from the whole blood of blood donor, herein its by the instrument of fluid circuit and Parts are handled to cause whole blood to be separated into desired erythrocyte and plasma component.Blood donor is whole Remain connected to system during individual program, and all fluids are maintained at the kit being intended for single use Fluid path in until complete program.As " one way " system, whole blood is the most only once Through flow circuits, and blood constitutent is not had to return to blood donor.
Can need not to be carry out leukocyte in the past from collecting the erythrocyte that obtains.But, pass through The leukocyte that goes filtered can utilize be preferably integral with the loop that is intended for single use to remove white blood Ball filter or by being connected to the separating treatment loop of red blood cell collection container with using sterilization Realize.
Instrument preferably includes for inputting information and/or the operator interface therewith of display information, such as Touch screen, keypad, mouse, keyboard etc..Message display allow operator control program, Collect the information about its state and solve any error condition that they are likely to occur.
Turn now to accompanying drawing, see in Figure 16-19 in different operating level or basis in the operational phase Schematically showing of whole blood automatically collecting system (being typically expressed as 210) of the disclosure.System Preferably include the hardware component 212 that can re-use and the pre-assembled sterilization being intended for single use is disposable Fluid circuit parts 214, the hardware component 212 that can re-use preferably includes pump, fixture and pressure Force transducer is to control fluid flowing, the pre-assembled sterilization disposable fluid circuit portion being intended for single use Part 214 may be mounted to hardware component and includes that various container/bag, blood donor are close to device or fistula With blood separation chamber, all parts all pass through fluids for sterilization path such as flexible plastic tube phase Connect.Container/bag is the most folding, and is made up of suitable plastic material, such as ability Territory is well-known.The material of container can be different according to use and can include without plasticizer Material, such as without the polymer of DEHP, particularly but non-exclusively, deposit for erythrocyte Storage.
More specifically, shown fluid circuit parts or module 214 include that blood donor is close to device 216, it includes being worn as in extracting whole blood from blood donor and whole blood introduces fluid circuit 214 First length 218 of the pipeline of the extraction pipeline crossed.Blood donor preferably includes close to device 216 Pin, and especially for utilizing needle guard to improve blood donor's comfort level to prevent in the case of needs The small gauge needle (18-21 specification) that accidental needle sticks enters.Pipeline 218 be typically expressed as 220 Blood separating mechanism is connected, and as it has been described above, so that whole blood is introduced seperator.
Second length 222 of pipeline provides seperator 220 and for receiving the red blood of the concentration of separation Fluid communication between first container of ball/bag 224, and the 3rd length 226 of pipeline provides and divides Disembark 220 and fluid communication between the second container/bag 228 receiving blood plasma.
Fluid circuit 214 also includes being contained in the anticoagulant source in the 3rd container 230 (such as, CPD), the 3rd container 230 is joined to the pipeline of pipeline 218 by means of such as Y-connector The 4th length 232 connect with the first length 218 of pipeline.Fluid circuit 214 can also wrap Include container/bag 224 to be transported to for erythrocytic antiseptic solution source.Antiseptic solution can To be contained in the separation bag connected with container 224.Alternately, container 224 can be with pre-fill It is filled with the preservative for receive erythrocytic amount wherein during collection procedure enough molten The amount of liquid.
Fluid circuit 214 also includes for before the process of donating blood and donate blood during process sterilely Collect the overall sampler 234 of blood sample.Sampler 234 includes by pipeline 218 With the 5th length 236 of the pipeline connecting upstream between pipeline 232 and blood donor are close to device The bag of the first length 218 connection of pipeline, anticoagulant is introduced by pipeline 232.Pipeline 236 Preferably connected with pipeline 218 by Y-connector or similar device.
Persistently hardware component 212 preferably includes and coordinates with pipeline 218 whole blood pump to be delivered to point From the first pump 238 of device 220 with coordinate with pipeline 222 with by from split cavity 220 The erythrocyte substantially concentrated is transported to the second pump 240 of the first collection container 224.Pump 238, 240 preferably include having for oppressing pipeline to force fluid to move through one of them Or the wriggling of the rotor of multiple roller or roller pump, but other suitable pump can also be used to set Meter, such as flexible diaphragm pump.Hardware component preferably includes coordinating with pipeline 232 to resist Solidifying agent is transported to extract the 3rd pump 242 of circuit line 218, and whole blood is by extraction circuit line 218 are transported to seperator 220.3rd pump 242 provides the metering that anticoagulant flows, and also helps In filling and the rinsing of system, as described herein below.But, the 3rd pump 242 is optional, And can by gravity stream be metered into whole blood extraction pipeline 218 anticoagulant, the size of pipeline 232 It is set to collection procedure duration and suitable flow is provided.
Hardware component 212 preferably include being respectively used to inaccessible and opening conduits sections 218, 232, the fixture 244,246,248 and 250 of 222 and 226.Term " fixture " is at this quilt Broadly use, and include that any flow path (such as duct segments) with fluid circuit is joined Close to selectively allow for or to stop fluid to flow through mechanism therein.Hardware component 212 is also Be preferably incorporated in extraction circuit line 218 near or adjacent to pin (pressure transducer 252) with And near or adjacent to the entrance (pressure transducer 254) of seperator 220 to monitor inlet pressure, The pressure transducer 252,254 that such as detection vein is collapsed.Further preferably at least the first container 224 provide weight scale (not shown) to provide the feedback about the red blood cell volume collected.
Keeping consistent with another aspect of the present disclosure, the hardware component that can re-use preferably includes Programmable Logic Controller 256, is used for activating pump and fixture and monitors pressure transducer and weight scale makes Whole blood collection program can substantially automatization.Controller 256 includes programmable microprocessor, And preferably including operator interface therewith, such as touch screen and message display are to allow operator defeated Enter and check data and control program, collect and be likely to occur about the information of its state solution Any " mistake " condition.
In order to utilize so far disclosed automatization blood collection systems 210 perform automatically collecting and Separable programming, disposable fluid circuit 214 is loaded at the hardware component 212 that can re-use On operating position, as shown in Figure 16 of accompanying drawing.The stage shown in Figure 16 or time interim, System fluid loads substantially to remove air moistening filter membrane.In filled stage, First fixture 244 is turned off to prevent blood donor close to device 216 and blood separation chamber 220 Between fluid communication, and anticoagulant via pump 240 and 242 by pipeline 218, seperator 212 and pipeline 222 pump to load system.Then utilize blood donor close to the pin of device for donating blood Person carries out venipuncture so that whole blood enters pipeline 218.At this point it is possible to treat 234 by means of sampling Whole blood is sampled.
Turn to Figure 17, after loading, open the first fixture 244 so that whole blood is through pipeline 218 It flow to blood separator 220, to start the collection/separation phase of collection procedure via pump 238. Continue metering by means of the 3rd pump 242 through duct segments 232 to extraction pipeline duct segments The anticoagulant of 218.Erythrocyte leaves seperator 220 through pipeline 222.4th fixture 250 quilt Open to allow blood plasma leave seperator 220 and advance to the second collection appearance through pipe 226 Device 228.Whole blood stream is provided seperator 220 by the first pump 238, and inlet pressure is by sensor 254 Monitoring, erythrocyte is pumped from seperator chamber 220 by the second pump 240 simultaneously.First pump 238 And second the flowing difference between pump 240 force the blood plasma of separation to leave seperator 220 to enter second Collect container 228.
With reference to Figure 18, when reaching predetermined body at the first erythrocytic volume collected in container 224 Time long-pending (as that detected by weight scale, by the first weight measurement collecting container 224), Weight scale will provide prompting controller by closing the first fixture 244 eventually to controller 256 The only signal of collection procedure, thus inaccessible extraction pipeline 218.Blood donor is permissible close to device 216 Withdraw from from blood donor at this moment.If system to rinse, then close the 4th fixture 250 with The inaccessible flow line 226 to the second collection container 228 for blood plasma.First pump 238 is stopped Only, and the 3rd pump 242 continues to be transported to anticoagulant seperator 220, and anticoagulant is by pipe simultaneously Road sections 222 is discharged into the first collection container 224.
Turn to Figure 19, at the end of rinse cycle, the second fixture 246 and the 3rd fixture 248 quilt Close, and the second pump 240 and the 3rd pump 242 are stopped.
Now, accommodate substantially concentrate erythrocytic first collect container 224 can with once Property fluid circuit 214 separates to store or facilitating leukocyte filter.This can be by simply Hang and collect container 224 and allow erythrocyte to go through leukocyte filter to be filled into for gravity Whole storage container and complete.But, according to another aspect of the present disclosure, and as shown in figure 20, Can provide and collect, by duct segments 260 and second, the 3rd collection that container 224 is in fluid communication Container 258, duct segments 260 is by between the outlet and the second pump 240 of seperator 220 Duct segments 222 on Y-connector and be in fluid communication with duct segments 222.3rd fixture 248 can be opened to allow the erythrocyte concentrated to flow out collection container 224, simultaneously the second pump subsequently 240 are activated and to pump to force the erythrocyte flow of concentration to go through in the opposite direction white Blood cell filter 262 also enters collection container 258.The pressure produced by pump 240 is with erythrocytic The leukocyte filter of gravity supply compares significantly accelerated filter process.
As other replacement, go the leukocyte can be about whole blood during the extraction stage of operation Perform.Turning to Figure 21 and 22, extraction circuit line 218 can include consistent with pipeline 218 Remove leukocyte filter 264.Filter 264 is positioned at the upstream of the first pump 238 and makes pump by right Blood applies enough extraction force to pass filter 264 during collecting to extract blood.Go Leukocyte filter 264 may be located in duct segments 218, and anticoagulant is introduced into the upper of system Trip (as shown in figure 21) or anticoagulant are introduced into the downstream of extraction pipeline 218 (such as Figure 22 institute Show).It is placed on anticoagulant attachment downstream to allow complete to use anticoagulant after blood donor extracts Any remaining whole blood from filter 264 is rinsed in agent.And, at extraction circuit line 218 Middle placement goes leukocyte filter to eliminate the needs that separation downstream is gone leukocyte filter step, Thus make blood collection procedure in hgher efficiency further.
Expect that automatization described herein one way whole blood collection system and method is by realizing whole blood It is separated into erythrocyte and plasma component and improves blood collecting center without manual operation subsequently Efficiency and reduction running cost.Additionally, the blood donor being used together with system close in device The pin using relatively small dimension will improve blood donor's comfort level, use draw-off pump to allow system real simultaneously Now it is similar to the blood transfusion number of times of typical whole blood collection.It addition, it is complete by being controlled by microprocessor Blood is collected, including using the most integrated bar code reader and/or RFID technique, Provide the bigger data management usually not found in current manual whole blood collection method Chance.
According to another aspect of the present disclosure, it is described in washing biological cell such as blood cell below Or useful mthods, systems and devices in other blood or biological components.
VI. cell washing system and method
Biological cell washing may be used for multiple use.It is, for example possible to use cell washing is replaced Change the liquid medium that biological cell is suspended.In this case, second liquid medium is added to replace Change and/or dilute original liquid medium.Part original liquid medium and replacement liquid medium and cell Separate.Other replacement liquid medium can be added until the concentration of original liquid medium is less than certain One percentage ratio.Hereafter, cell can be suspended in, and such as, replaces in medium.
Cell washing can be also used for the cell in concentration or further concentrated liquid medium.Suspend Cell in liquid medium is washed so that a part of liquid medium separates and goes from by cell Remove.
And, cell washing may be used for removing less desirable micro-from the cell suspension of particle size The such as thick microgranule of grain or less desirable cellular material or " purification " desired cell suspension or other Liquid.
Method as described below, system and equipment may be used for any reason in above-mentioned reason And washed cell.More specifically, but the most without limitation, method as described below, system and set Thin for the blood that may be used for washing such as erythrocyte or leukocyte (leukocyte) or platelet etc. Born of the same parents.
In a particular implementation, the suspension comprising leukocyte in liquid culturing medium can To be washed to replace liquid with another kind of medium such as saline before using or processing further Body culture medium.The cell suspension comprising leukocyte in liquid culturing medium is carried and is introduced To seperator, such as rotate membrane separator.Rotate membrane separator and there is film filter, this film mistake Filter has the pore-size less than leukocyte.In one embodiment, including replacing liquid The liquid washing medium of medium such as saline is also added into seperator and cultivates Jie with diluent liquid Matter.Seperator be operated so that liquid through the hole of film and is extracted as garbage.At this In embodiment, along with liquid is extracted, washing medium is added so that obtained cell Suspension includes being suspended in the leukocyte replaced in liquid medium (such as, saline).
In another embodiment, cell suspension can be concentrated (by removing the supernatant) And the cell suspension of concentration is collected in the container of process kit.Replacement fluid can be introduced into Concentrating cells in seperator, with container combines, and cell hangs subsequently together with replacement fluid again Floating.If it is required, the cell/replacement fluid of settling flux can be introduced into seperator with the denseest Shrinking born of the same parents, the removal supernatant the cell concentrated with other replacement fluid settling flux.According to Needing, this circulation can be repeated.
Similar process can be used to wash the erythrocyte being suspended in liquid storage medium.Including hanging Float over the erythrocytic cell suspension in liquid storage medium can be washed using or entering one Step replaces liquid storage medium with another kind of medium such as saline before processing.Cell suspension is defeated Send and introduce seperator, such as rotating membrane separator.Rotate membrane separator and there is film filter, The pore-size of this film filter is less than erythrocyte.In one embodiment, it is also possible to will wash Wash medium, i.e. replace liquid medium such as saline and add seperator to diluent liquid storage Jie Matter.Seperator be operated so that liquid through the hole of film and is extracted as garbage.Along with Liquid is extracted, and adds washing medium so that obtained cell suspension includes being suspended in replacement Erythrocyte in liquid medium (that is, saline).Washing and/or replacement liquid can also be to comprise Allow the nutrient of the longer-term storage of cell and the storage medium of other component.Alternately, exist In another embodiment, first erythrocyte can be concentrated and remove to container, as led to above Often describe.Replacement fluid can be combined by the erythrocyte in container subsequently.Replacement fluid is permissible In being introduced directly into container or introduce seperator and pass seperator and subsequently enter container.
System, method and apparatus as described herein for cell washing make use of and include such as revolving The disposable external member of the seperator of transferring film seperator etc..There is the disposable pull rotating membrane separator Part is arranged on the hardware component of system, i.e. on segregation apparatus.Segregation apparatus include fixture, pump, Motor, air detecting sensors, pressure transmitter sensor, Hb detector, weight scale and Including control logic/microprocessor in the microprocessor.Control logic/microprocessor receive from The input data of operator and/or various sensor and signal also control the behaviour of fixture, pump and motor Make.
Cell suspension to be washed, i.e. suspend cell in media as well, can be placed on sterilization Disposable source container in, it is connected to disposable external member with disinfection way.Washing medium, than Such as saline or other suitable liquid, also connect with disinfection way or be pre-attached to disposable external member. Cell suspension is followed by the control logical operation fixture of device and pump with the pipeline by disposable external member Ring is to (rotation film) seperator.Wash solution is also passed by segregation apparatus by its control system The pipeline of disposable external member is directed to rotate membrane separator.Cell suspension and wash solution can be Rotate mixing in membrane separator, can mix before entering rotation membrane separator, or permissible Combine in container after cell suspension is the most concentrated.In rotating membrane separator, suspendible is situated between Matter be suspended in cell separation therein.Suspension medium and remaining washing medium (if suspendible Medium and washing medium already in connection with) leave through garbage port, and cell through separate from Ported.
If needing washing further and dilution, then washed cell recirculation can be made to pass There is the seperator of the wash solution of other volume.In one embodiment, " wash again " Cell can be passed to one or more during container, as described herein below.Device Control logical operation fixture and pump with by from during the cell suspension of container circulate through pipeline The entrance of membrane separator is rotated to the entrance or second rotating membrane separator.Add other washing Medium, and process repetition is until achieving the cell of acceptable amount or concentration.Containing cell Whole cell suspension is preferably collected in final products container.
According to the disclosure, Figure 23-25 shows and is such as but not limited to red blood at washing biological cell Exemplary system useful in ball and leukocyte.As it has been described above, disclosed detailed description of the invention Expection is schematic and nonrestrictive.Therefore, in one embodiment, described herein System include disposable external member 300(Figure 23 or 24) and hardware component or device 400(figure 25).It will be appreciated that the disposable process kit 300 shown in Figure 23 and 24 is in many aspects Identical and use common reference number to represent disposable process kit in Figure 23 and 24 Same or analogous element.With regard to disposable process kit in terms of structure or its purposes, This difference is described below.Disposable external member 300 is arranged on device 400(Figure 25) on, It is described in greater detail below.
As shown in figs. 23-24, seperator 301 is integrated into the most disposable external member 300 In.It addition, as described in more detail below, disposable external member 300 includes that pipeline, Y are even Connect device, one or more during sack, one or more sample treat, one or more finally Product sack, one or more garbage sack and one or more sterilizing filter.
Cell suspension to be washed is typically provided in source container 302, as shown in figs. 23 and 24, Source container 302 disconnects with disposable external member.As mentioned above, source container 302 can make Used time carries out being attached (with disinfection way).Source container 302 have one or more receiving port 303, 305, one of them nail adapter 304(Figure 23 that may adapt to receive disposable external member 300). More specifically, source container 302 is connected to disposable external member 300 via nail adapter 304, nail is even Connect device 304 and may be connected to entry port 303.More preferably, however, source container is (and therein Fluid) can not follow closely adapter (as shown in figure 24) and be sterilized by utilization with disinfection way Plug assembly such as BioWelder(can be purchased from Sartorius AG) or SCD IIB Tubing Welder(can be purchased from Terumo Medical Corporation) and enter.Can be provided for The second entry port 305 of fluid is extracted from source sack 302.
As Figure 23-24 further shown in, duct segments 306 can be optionally included in branch Sampling subelement at adapter 308.One branch of bifurcation connector 308 can include leading to To the fluid path 310 at sample sack or position 312.Sample sack or position 312 allow to collect and enter The sample of source fluid.Flowing to sample sack or position 312 is generally controlled by fixture 314 System.Another branch of bifurcation connector 308 is connected to pipeline 316.Pipeline 316 is connected to additionally Downstream branch adapter 318.Bifurcation connector 318 connects with pipeline 316 and pipeline 320, Its provide from during the fluid flow path of sack 322, as described in more detail below. Duct segments 324 extends from a port of bifurcation connector 318 and is joined to other downstream The port of bifurcation connector 326.The separation fluid path limited by pipeline 328 is also connected to point Prop up the port of adapter 326.Pipeline 328 can include for leading to second point in fluid entrance Adapter 326 and be eventually leading to seperator 301 flow path before filter from fluid The pipeline sterilization barrier filter 330 of any microgranule.
According to system disclosed herein, wash solution can be attached (or pre-attached) to external member 300. As shown in figs. 23 and 24, pipeline 332(limits flow path) it is preferably incorporated in its end Nail adapter 334.Nail adapter 334 be arranged to wash fluid container such as accommodate saline or The disposable sack (not shown) of other solution sets up flowing connection.Washing medium or fluid from Scrub stream body source through second nail adapter 334, through duct segments 332(this its by above The sterilization barrier filter 330 described filters) flow and arrive above-mentioned then across pipeline 328 The input of bifurcation connector 236.
Duct segments 336 limits and is connected at one end to the port of bifurcation connector 326 and is connected to The flow path of the ingress port of seperator 301.Preferably, according to the disclosure, seperator 301 Rotation membrane separator for the above-mentioned type.
Such as Figure 23, shown in 24 and 25, rotate membrane separator 301 and there is at least two port of export Mouthful.The outlet 646 of seperator 301 receives garbage (that is, the suspendible of dilution from washing Medium) and it is connected to limit the pipeline 338 of the flow path of waste product container 340.Discarded Thing product container includes the other connection end for sampling or withdraw from garbage in product container Mouth 341.
Seperator 301 preferably includes the second outlet 648 being connected to duct segments 342.Pipe The other end of road sections 342 is connected to bifurcation connector 344, and this bifurcation connector 344 is branched off into And define an access to one or more during container 322 flow path and lead to final products hold The flow path of device 350.Final products container 350 can also include that sample sack 352(sees figure 23) and entry port or luer connector 354.Figure 23 illustrates the pipe for having pre-attached The sample sack 352 of sub-keeper 352 allows the sample collection of final products.To sample sack 352 Flow-control preferably controlled by fixture 356.It is passed into the flow path of port 354 Controlled by fixture 358.
The method turning now to use kit 300 washing of Figure 23 and 24, first will once Property external member 300 is arranged on the panel 401 of segregation apparatus (that is, hardware) 400, such as Figure 25 Shown in.Device 400 includes controlling the peristaltic pump of flowing, fixture and biography through disposable external member Sensor.More specifically, the control of pump, fixture etc. is by micro-process of the software-driven of device 400 Device/controller provides.Duct segments 362,366 and 368(figure 23 illustrates) select Property ground with peristaltic pump 402,404 or 406(as shown in figure 25) mate.(if necessary, Garbage pipeline pump sections 368 can be repositioned on seperator export pipeline 342.) once by one Secondary property external member 300 is installed to the control panel 401 of device 400, the most as previously described by nail Adapter 304 or by sterilization connect be attached the cell suspension in product sack 302.Arrange Washing medium in container (not shown) is the most attached.According to the operation of device 400, Fixture 360 is opened and allows cell suspension to flow from product container 302.
The flowing of cell suspension is advanced through by the effect of peristaltic pump is specified by pump sections 362 Pipeline 324 also enters rotation membrane separator 301.Similarly, the washing medium work by peristaltic pump With advancing through by having the pipe specified at the pump sections 366 of the valve 362 and 364 of open position The length in road 328.Washing medium flows through pipeline 332, sterilization barrier filter 330, pipe Road 328, Y-connector 326 also enter rotation membrane separator 301.Washing medium and cell suspension Rotation membrane separator 301 can be sequentially introduced into, it is allowed to the mixing of suspension and wash solution occurs In the chamber (gap) of seperator 301 or during the course in container 322, as described herein below 's.Alternately, washing medium and cell suspension can be in (examples before introducing seperator 301 As) combine at the second bifurcation connector 326.
In another replacement, first cell suspension can introduce seperator 301 from source container 302, As being generally described above.Cell suspension concentrates in seperator 301, it is allowed to the supernatant is worn Cross film, through outlet port 382, arrive waste product container 340.The cell concentrated passes Port 384 leave seperator 301 and be drawn towards during container 322.
The cell once concentrated completes from the separation of the supernatant of cell suspension, from replacement fluid Replacement fluid is introduced seperator 301(to flush out any residual cells by container (not shown)) And again pass through container 322 during port 384 is incorporated into.Concentrate cell be resuspended in as During shown in 23 in the replacement fluid in container 322.It is it desired to or needs other Washing, then system can programmed or other control with by the cell/replacement fluid of settling flux (again) introducing in seperator 301, the cell wherein concentrated separates repetition with the supernatant. Final cell product is collected in final products container 350, and herein, final cell product can To utilize other replacement fluid settling flux.
Unrelated with the order that cell suspension/wash solution introduces or disposable external member used, device Spinning movement cause cell from the remainder of its fluid suspended and/or to divide from wash solution From.Preferably, the supernatant and wash solution are dividing through film, the most desired cell concentration In the chamber disembarked.Washing medium and the garbage of supernatant medium is included by isolated Leave port 382 and flow to waste product container 340 through pipeline 338.The stream of garbage A dynamic part by peristaltic pump control through the pipeline 338 specified by pump sections 368 arrives Waste product sack 340.
As described above, leaving with the cell suspension separated of concentration rotates membrane separator 301 Second outlet 384.If need not further wash, then control system closes fixture 370 And open fixture 372.The closedown of fixture 370 prevents washed cell suspension from flowing through pipeline 346 And be passed through pipeline 348 and be directed to final products sack 350.Final products container 350 has Input for cell suspension that is that receive separation and that wash.Final products container 354 is connected to Weight sensor 374.Segregation apparatus measures the weight 374 of container to determine at final products container The volume of the cell collected in 350 is the most within the acceptable range and it is thus determined that cycles of washing Whether complete.
If it is desire to or need washing further of the cell suspension separated, the then control of segregation apparatus System processed is closed fixture 372 and fixture 376 and opens fixture 370.The closedown of fixture 372 prevents Cell suspension flows through pipeline 348 and is passed through sack 322 during pipeline 346 is directed to.Cross In journey, sack 322 has the entrance of the cell suspension for receiving separation.During sack 322 It is connected to weight sensor 378.The control system of segregation apparatus determines and is sensed by weight sensor Weight be present in the cell suspension determining whether enough separation during in sack 322 To carry out another cycles of washing.If it is determined that there is enough suspensions, and wish washing further, Then the control system of seperator device open fixture 376 with open and guide dilution and separate Cell suspension pass during the outlet of sack 322, through pipeline 320, enter bifurcation connector 318, and through air monitor sensor 380.Air monitor sensor 380 detect through Air in the cell suspension of pipeline 324.Control and operation measurement device is from air monitor The reading of sensor 380 also determines and to carry out other process.
Including the cell in the suspending medium being suspended in dilution separation cell suspension the most again Through washing process, as described above.Washing process can be repeated as many times as desired and preferably Ground is until the cell suspension with separation of dilution has the acceptable residual concentration of suspending medium. Being collected in final products sack 350 with the cell suspension separated of final dilution.
Alternately, except repeatedly processing through in addition to the fluid of container during single, it is also possible to By using container 322(and final products container 350 combination during two or more) Carry out " batch-type " processing routine.
The disposable process kit 300 of Figure 24 is particularly suitable for this batch-type " process. According to the cell washing procedure of the disposable external member 300 using Figure 24, at the beginning of initial suspending medium Begin the cell that ground separates removed from seperator 301 and be introduced into during one of container 322a. Replacement fluid is introduced into container 322a and cell settling flux.In container 322a the cell of settling flux with After can be introduced into seperator 301, they separate with the supernatant at this.The cell concentrated passes Container 322b during new (second) is left and is introduced in outlet 648 in seperator 301. Other replacement fluid can be introduced into during container 322b, and process repeat.If it is required, Then utilize container (not shown) during other new (the 3rd).Final cell product subsequently It is collected in final products container 350, as described above.
According to above-mentioned " batch-type " cell washing process, duct segments 370a, 370b With 320a, 320b can be associated with fixture (not shown) with control to and during multiple The flowing of container 322a and 322b.It is therefoie, for example, the fixture on pipeline 370a will be opened, Fixture on pipeline 370b would be closed such that the cell being present in seperator 301 is drawn simultaneously Lead container 322a during (first).
For other washing, it is resuspended in the cell in the new replacement fluid in container 322a Being introduced into seperator 301, in seperator 301, cell separates with the supernatant, as retouched before State.The fixture that the control system of device 400 is closed in duct segments 370a (does not has in Figure 24 Have and illustrate) and opening conduits sections 370b on fixture (being shown without in Figure 24) with allow Cell flows into container 322b during new (second).After final washing, sections 370a, Fixture (not shown) on 370b etc. is closed and fixture 372(is as the most such as, institute in fig 23 Show) it is opened to allow final products to be collected in container 350.
Figure 24 shows the front panel 401 of segregation apparatus 400;I.e. hardware, it includes peristaltic pump 402,404 and 406.As described above, from the pump sections 362,364 of disposable external member Optionally it is associated with peristaltic pump 402,404 and 406 with 368.Peristaltic pump pump sections 362, At 364 and 368 hinged with the fluid external member of Figure 23 and before making the cell suspension in disposable external member Enter, as the skilled person will appreciate.Control and operation device 400 also include fixture 410, 412、414.Fixture 410,412,414 and 416 is used for controlling cell suspension through disposable The flowing of the different segment of external member, as described above.
Device 400 also includes that multiple sensor is to measure various conditions.The output of sensor is by filling Put 400 uses to circulate with operated wash.One or more pressure transmitter sensors 426 can set Put on device 400 and be associated with during program with disposable external member 300 at some point Monitoring pressure.(such as, pressure transmitter 426 is desirably integrated into pipeline pressure monitoring position At duct segments 336), to monitor the pressure in seperator 301.Air monitor 438 passes Sensor can also be associated with disposable external member 300 as required.Air monitor 438 is to appoint Choosing and can be arranged to detect fluid/air interface position.
Device 400 include final sack, during sack, cell suspension sack and any additionally The sack weight scale 440,442,444 and 446 that can hang and weigh respectively.Sack Weight is monitored by weight sensor and is recorded during washing procedure.According to weight sensor Measurement result, device determines whether that each sack is empty, the fullest or full up and controls Make this control and the parts of operation device 200, such as peristaltic pump and fixture 410,412,414, 416,418,420,422 and 424.
Device 400 includes causing at least one driving indirectly driven rotating membrane separator 301 Unit or " rotator " 448.Rotator 448 by being connected by device 400 and can be operated Driving motor forms, and it is coupled to rotate the annular magnet driving including at least one pair of permanent magnet Component.Along with endless drive rotates, magnet corresponding in rotating the housing of membrane separator it Between magnetic cause rotate membrane separator housing in rotator rotate.
Figure 26-28 diagrammatically elaborates cell washing process disclosed herein.Step described below Suddenly being performed by the microprocessing unit of the software-driven of device 400, some step is by operator Perform, as mentioned.It is turning initially to Figure 26, in step 500 place opening device.Device is carried out Self calibration checks 502, including checking peristaltic pump, fixture and sensor.Device 400 is pointed out subsequently User inputs the procedure parameter (step 504) of selection, washing procedure to be performed, to wash The amount of the cell suspension washed, the washing quantity carried out etc..Operator can select and defeated subsequently Enter the procedure parameter (step 506) for washing procedure.
Device (passing through controller) confirms that parameter input 506 prompting operator loading subsequently (walk Rapid 510) disposable external member.Disposable external member is loaded (step 512) to dress by operator subsequently Put on the panel of 400.After being mounted with disposable external member, the installation (step shown in device confirmation Rapid 514).
After disposable external member is mounted, device automatically checks to determine that disposable external member is No it is improperly seated (step 516).After device determines that disposable external member is properly installed, Controller prompting operator connects cell suspension and washing medium (step 518).Operator is subsequently Washing medium (such as, but be not limited to saline) is connected to disposable external member via nail adapter (step 520), as previously described.Operator is then by the cell suspension warp in product sack It is connected to disposable external member (step 522) by nail adapter.
As shown in figure 27, after cell suspension and washing medium are connected to disposable external member, Operator confirms that solution is connected (step 524).Device prompting operator takes out cell suspension sample Product (step 526).Operator or device then turn on sample sack fixture 528 to introduce fluid into Sample sack (step 546).Once sample sack is filled, and it is subsequently sealed and from disposable pull Part removes (step 542).Operator confirms that (step 544) sample has been taken out.Moving After sample sack, disposable external member is filled (step 546) to carry out washing process.
Then the controller of segregation apparatus starts washing process.Cell suspension to be washed holds from it Device (such as, the 302 of Figure 23) is delivered to rotate membrane separator 301 through disposable external member. Equally, washing medium is delivered to rotate membrane separator 301 from its source through disposable external member.Excellent Selecting in embodiment, during the initial cell of cell suspension is concentrated and/or is collected in, sack (is used In processing further) or be collected in the final products sack removed from disposable external member subsequently. If needing (other) washing or the dilution of cell suspension, then during cell in sack Suspension can utilize same or different washing medium to carry out washing (second after said process Secondary).Before each cycles of washing terminates, measure and record cell suspension volume or weight (step Rapid 550).When the concentration of cell to washing medium reaches acceptable level, final products bag Son fills up.
As shown in figure 28, once have collected the final products of intended volume, control and operate device Prompting operator samples and seals final products sack (step 552).Sample sack is attached to Finished product sack.Operator seals subsequently and removes final products sack from disposable external member and washes The cell suspension (step 552) washed.Then agitation final products sack (556).Operator is led to Cross and remove fixture and open sample sack (step 558).Sample sack is allowed to fill (step 560). Once sample sack is filled, and fixture is closed and sample sack is sealed and is removed (step 562).Then operator seals disposable external member pipeline (step 564) and confirms product sack Through being sealed and being removed, sample sack is already filled up and is removed, and disposable external member pipe Road is sealed (step 566).Control and then operation device points out operator to remove once Property external member, as shown in step 568.Then operator removes and abandons disposable external member, as Shown in step 570.
Therefore, disclose improvement rotate membrane separator and use such rotation film method and System.Described above is intended for purpose of demonstrating, and the scope of the present disclosure is not limited to this by expection The disclosed any concrete grammar of literary composition, system or equipment or device.

Claims (13)

1. a blood filter device, including:
Cylindrical housing, it has inwall;
Internals, it is arranged on the inside of described housing and has outer surface;
The inwall of described housing and/or the outer surface of described internals include that the outer surface towards wall or described internals with described housing is spaced apart to limit betwixt the perforated membrane of annular gap;
Described housing and described internals are the most rotating;
Entrance, it will be for including that blood plasma and erythrocytic whole blood introduce described annular gap;
First outlet, it is for being directed to collect container by the blood plasma of described film;And
Second outlet, it for guiding remaining blood constitutent from described annular gap;
The surface area of wherein said film be enough to so that the erythrocyte time of staying in described annular gap is not enough to cause the speed of excessive hemolysis to take separated plasma.
Blood filter device the most according to claim 1, wherein said internals has more than 1.1 " diameter and/or more than 3.0 " Filter length.
3., according to blood filter device in any one of the preceding claims wherein, wherein said internals has up to 2.2 " diameter and up to 7.5 " Filter length.
Blood filter device the most according to claim 3, wherein said internals has 1.65 " diameter and 5.52 " Filter length.
5. according to the blood filter device according to any one of claim 1-2, also including: HT region, wherein, internals is covered by described film;Non-perfusing region;And circumferential ridge, the extension from the inwall of described housing or the outer wall of described internals of the described circumferential ridge is to reduce described annular gap therebetween, and described circumferential ridge is by described HT region from described non-perfusing region separately.
Blood filter device the most according to claim 5, wherein said circumferential ridge has the axial dimension of the size being the most described annular gap.
Blood filter device the most according to claim 5, wherein said entrance and the second outlet and the described HT regional connectivity of described device.
8. a blood filter device, including:
The housing of generic cylindrical, it has inwall;
Internals, it is arranged on the inside of described housing and has outer surface;
The inwall of described housing and/or the outer surface of described internals include that the outer surface towards wall or described internals with described housing is spaced apart to limit betwixt the filter membrane of annular gap, and the described outer surface of described internals has the HT region and non-perfusing region covered by described film;
Described housing and described internals are the most rotating;
Circumferential ridge, the extension from the inwall of described housing or the outer surface of described internals of the described circumferential ridge is to reduce described annular gap therebetween, and described circumferential ridge is by described HT region from described non-perfusing region separately.
Blood filter device the most according to claim 8, wherein said circumferential ridge has the axial dimension of the size being the most described annular gap.
10. a design includes the method for blood filter device of perforated membrane, described blood filter device includes shell body and inner rotator, described inner rotator has length and radius, it is arranged in described shell body, for rotating relative to described shell body, annular gap is limited between the outer surface and the inner surface of described shell body of described inner rotator, the described outer surface of described inner rotator includes filter membrane, described shell body includes entrance, the first outlet connected with described gap, described shell body and/or inner rotator include the second outlet that the side deviating from described gap with described film connects, step includes:
Utilize from existing defecator semiempirical obtain operation input development model, described existing defecator has the geometry specified input and the perforated membrane of specified size of rotor radius, the width of annular gap and length, including blood donor's hematocrit, access ports blood flow, velocity of rotation and effective film area, to obtain the appointment output of plasma flow rate and plasma hemoglobin concentration, and the integration being input to described output described in execution is correlated with;
What described model was applied to varying dimensions assumes that defecator is to specify output to obtain predictive value for the length of described inner rotator and radius for described;
Create the three-dimensional curve diagram of the relation demonstrated between described varying dimensions and described appointment output;
Check for the described described predictive value specifying output to obtain;And
The filter membrane surface that relatively selects based on the described predictive value obtained by the application of described model is amassed.
11. methods according to claim 10, the film surface area selected in it provides the film surface area improving one or more filtering features.
12. methods according to claim 11, wherein select do not have the filtration in the case of excessive dissolution for the diameter of described inner rotator and Filter length with the erythrocyte allowing in blood according to checking of described three-dimensional curve diagram.
13. according to the method that in claim 10-12, any one is described, and wherein said model is applied to assume defecator, and for the inside radius of shear gap, described defecator has the size of change.
CN201280012852.1A 2011-03-11 2012-03-09 Membrane separation device, the system and method utilizing this device and data management system and method Active CN103429321B (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US201161451903P 2011-03-11 2011-03-11
US61/451,903 2011-03-11
US201161537856P 2011-09-22 2011-09-22
US61/537,856 2011-09-22
US201161538558P 2011-09-23 2011-09-23
US61/538,558 2011-09-23
US201161550516P 2011-10-24 2011-10-24
US61/550,516 2011-10-24
PCT/US2012/028492 WO2012125457A1 (en) 2011-03-11 2012-03-09 Membrane separation devices, systems and methods employing same and data management systems and methods

Publications (2)

Publication Number Publication Date
CN103429321A CN103429321A (en) 2013-12-04
CN103429321B true CN103429321B (en) 2016-08-24

Family

ID=46831065

Family Applications (6)

Application Number Title Priority Date Filing Date
CN201280012876.7A Active CN103415334B (en) 2011-03-11 2012-03-09 Membrane separation device, the system and method utilizing this device and data management system and method
CN201280012852.1A Active CN103429321B (en) 2011-03-11 2012-03-09 Membrane separation device, the system and method utilizing this device and data management system and method
CN201280012867.8A Active CN103429308B (en) 2011-03-11 2012-03-09 Membrane separation device, the system and method utilizing this device and data management system and method
CN201280012856.XA Active CN103429323B (en) 2011-03-11 2012-03-09 Membrane separation device, the system and method utilizing this device and data management system and method
CN201280012854.0A Active CN103415329B (en) 2011-03-11 2012-03-09 Membrane separation devices, systems and methods employing same, and data management systems and methods
CN201280012879.0A Active CN103429309B (en) 2011-03-11 2012-03-09 Membrane separation device, the system and method utilizing this device and data management system and method

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CN201280012876.7A Active CN103415334B (en) 2011-03-11 2012-03-09 Membrane separation device, the system and method utilizing this device and data management system and method

Family Applications After (4)

Application Number Title Priority Date Filing Date
CN201280012867.8A Active CN103429308B (en) 2011-03-11 2012-03-09 Membrane separation device, the system and method utilizing this device and data management system and method
CN201280012856.XA Active CN103429323B (en) 2011-03-11 2012-03-09 Membrane separation device, the system and method utilizing this device and data management system and method
CN201280012854.0A Active CN103415329B (en) 2011-03-11 2012-03-09 Membrane separation devices, systems and methods employing same, and data management systems and methods
CN201280012879.0A Active CN103429309B (en) 2011-03-11 2012-03-09 Membrane separation device, the system and method utilizing this device and data management system and method

Country Status (9)

Country Link
US (7) US9381291B2 (en)
EP (7) EP2683471B1 (en)
JP (8) JP5897612B2 (en)
CN (6) CN103415334B (en)
AU (6) AU2012229313B2 (en)
BR (6) BR112013022568B1 (en)
CA (6) CA2825920C (en)
RU (6) RU2597140C2 (en)
WO (6) WO2012125480A1 (en)

Families Citing this family (127)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160321480A1 (en) * 2005-12-09 2016-11-03 Tego, Inc. Methods and systems for rf communications in blood-extraction procedures
US9361568B2 (en) 2005-12-09 2016-06-07 Tego, Inc. Radio frequency identification tag with hardened memory system
US9744498B2 (en) 2011-03-11 2017-08-29 Fenwal, Inc. Disposable fluid circuits and methods for cell washing with on-line dilution of cell feed
US9381291B2 (en) * 2011-03-11 2016-07-05 Fenwal, Inc. Membrane separation devices, systems and methods employing same and data management systems and methods
US10130751B2 (en) 2011-03-11 2018-11-20 Fenwal, Inc. Membrane separation and washing devices, systems and methods employing same, and data management systems and methods
US9717842B2 (en) 2011-09-22 2017-08-01 Fenwal, Inc. Disposable fluid circuits and methods for cell washing
US9164078B2 (en) 2012-06-15 2015-10-20 Fenwal, Inc. Process for predicting hematocrit of whole blood using IR light
CN103861161B (en) * 2012-12-18 2016-06-08 苏州排头兵药业科技有限公司 The preparation method of Washed Red Blood Cells device and Washed Red Blood Cells
DE212013000295U1 (en) 2013-05-06 2016-02-02 Hitachi Chemical Co. America, Ltd. Devices for capturing target molecules
US9603986B2 (en) * 2013-08-30 2017-03-28 Fenwal, Inc. Device and method for processing and producing autologous platelet-rich plasma
US10036006B2 (en) 2013-10-21 2018-07-31 Biomet Biologics, Llc Cell washing device using a wave
WO2015130778A1 (en) * 2014-02-25 2015-09-03 Biomet Biologics, Llc Cell filter separation system
US10376627B2 (en) 2014-03-24 2019-08-13 Fenwal, Inc. Flexible biological fluid filters
US9796166B2 (en) 2014-03-24 2017-10-24 Fenwal, Inc. Flexible biological fluid filters
US10159778B2 (en) 2014-03-24 2018-12-25 Fenwal, Inc. Biological fluid filters having flexible walls and methods for making such filters
US9968738B2 (en) 2014-03-24 2018-05-15 Fenwal, Inc. Biological fluid filters with molded frame and methods for making such filters
US9782707B2 (en) 2014-03-24 2017-10-10 Fenwal, Inc. Biological fluid filters having flexible walls and methods for making such filters
JP6426200B2 (en) * 2014-04-30 2018-11-21 フェンウォール、インコーポレイテッド Methods of controlling fouling and complement protein activation during rotary membrane filtration of plasma from whole blood
US10550148B2 (en) 2014-06-16 2020-02-04 Emd Millipore Corporation Methods for increasing the capacity of flow-through processes
WO2015195452A2 (en) 2014-06-16 2015-12-23 Emd Millipore Corporation Single-pass filtration systems and processes
KR101938948B1 (en) 2014-06-25 2019-01-15 이엠디 밀리포어 코포레이션 Compact spiral-wound filter elements, modules and systems
WO2016014350A1 (en) * 2014-07-21 2016-01-28 Avery Dennison System, method, and apparatus for displaying proprietary information within a quick response (qr) code
US10335078B2 (en) 2014-08-04 2019-07-02 General Electric Company Device for separation and collection of plasma
US9950321B2 (en) 2014-08-04 2018-04-24 General Electric Company Device for separation and collection of plasma
CN106999347A (en) 2014-08-08 2017-08-01 弗雷蒙科学公司 The intelligent bag used in the physiology and/or physical parameter of bag of the sensing equipped with biological substance
US20160045932A1 (en) 2014-08-18 2016-02-18 Fenwal, Inc. Anti-Thrombogenic Porous Membranes And Methods For Manufacturing Such Membranes
US10905819B2 (en) * 2014-08-19 2021-02-02 Fenwal, Inc. Systems and methods for automated recovery of white blood cells after producing a leuko-reduced blood product
EP2987512B1 (en) 2014-08-21 2017-03-22 Fenwal, Inc. Parallel processing of fluid components
US10172996B2 (en) * 2014-08-22 2019-01-08 Fenwal, Inc. Medical solution authentication
CN108325391B (en) 2014-08-29 2021-05-18 Emd 密理博公司 Method for filtering a liquid feed
KR102188947B1 (en) 2014-08-29 2020-12-09 이엠디 밀리포어 코포레이션 Single pass tangential flow filtration systems and tangential flow filtration systems with recirculation of retentate
US9498567B2 (en) 2014-09-29 2016-11-22 Fenwal, Inc. Systems and methods for controlling the return phase of a blood separation procedure
US9486590B2 (en) 2014-09-29 2016-11-08 Fenwal, Inc. Automatic purging of air from a fluid processing system
US9953193B2 (en) 2014-09-30 2018-04-24 Tego, Inc. Operating systems for an RFID tag
WO2016065005A1 (en) * 2014-10-21 2016-04-28 Colorado State University Research Foundation Portable particle spectrometer
US10400216B2 (en) 2014-12-18 2019-09-03 Fenwal, Inc. Methods for cell washing with on-line dilution of cell feed
US10220132B2 (en) 2014-12-19 2019-03-05 Fenwal, Inc. Biological fluid flow control apparatus and method
US10688233B2 (en) 2014-12-19 2020-06-23 Fenwal, Inc. Method and system for the automated processing of biological fluid during low level alert condition
US9833557B2 (en) 2014-12-19 2017-12-05 Fenwal, Inc. Systems and methods for determining free plasma hemoglobin
US11298446B2 (en) 2014-12-19 2022-04-12 Fenwal, Inc. Systems and methods for calibrating pump stroke volumes during a blood separation procedure
US10994068B2 (en) * 2015-01-26 2021-05-04 Stichting Sanquin Bloedvoorziening Methods and systems for the detection and removal of pathogens from blood
CN105987843B (en) * 2015-03-23 2021-06-22 爱科来株式会社 Method for isolating or detecting rare cells
US9855382B2 (en) 2015-03-31 2018-01-02 Biomet Biologics, Llc Cell washing device using standing acoustic waves and a phantom material
US10376620B2 (en) * 2015-04-02 2019-08-13 Fenwal, Inc. Systems and methods for leukoreducing a red blood cell-containing fluid and concentrated red blood cells
GB2598499B (en) * 2015-06-05 2022-05-25 Novartis Ag Flow-through paramagnetic particle-based cell separation and paramagnetic particle removal
ES2927806T3 (en) * 2015-06-08 2022-11-11 Becton Dickinson Co plasma extractor
EP3302764A1 (en) 2015-06-08 2018-04-11 Becton, Dickinson and Company Filtration cell and method for filtering a biological sample
RU2675232C2 (en) * 2015-06-19 2018-12-18 Богдан Иванович Асатуров Method for obtaining, separation and examination of components of biological fluids and device for its implementation
US10254916B2 (en) 2015-06-29 2019-04-09 Fenwal, Inc. Systems and methods for monitoring and correcting defects and tubing installation errors for blood processing systems
US10458920B2 (en) 2015-08-17 2019-10-29 Fenwal, Inc. Systems and methods for ensuring proper tubing installation for fluid processing systems
US10434240B2 (en) 2015-08-17 2019-10-08 Fenwal, Inc. Methods and systems for processing and washing a photopheresis mononuclear cell product
US11028443B2 (en) 2015-08-31 2021-06-08 Showa Denko Materials Co., Ltd. Molecular methods for assessing urothelial disease
US10730058B2 (en) 2015-09-14 2020-08-04 Fenwal, Inc. Apparatus, systems and methods for storing, treating and/or processing blood and blood components
WO2017066447A1 (en) * 2015-10-13 2017-04-20 Fenwal, Inc. Fluid processing and circuit array, system and apparatus
EP3394238A1 (en) * 2015-12-22 2018-10-31 GE Healthcare Bio-Sciences Corp. Improvements in and relating to instruments for processing cells
WO2017109071A1 (en) 2015-12-22 2017-06-29 Ge Healthcare Bio-Sciences Corp. Improvements in and relating to cell harvesting apparatus
US11311842B2 (en) * 2015-12-28 2022-04-26 Fenwal, Inc. Membrane separation device having improved filtration velocity
US11383015B2 (en) 2016-01-11 2022-07-12 Fenwal, Inc. System and method for plasma purification prior to mononuclear cell collection
US10329530B2 (en) 2016-01-18 2019-06-25 Fenwal, Inc. Cell washing system and methods for washing small volumes of cells
EP3203398B1 (en) * 2016-02-08 2019-05-08 B. Braun Avitum AG Method for setting up a fluid processing medical apparatus
US10493409B2 (en) 2016-03-02 2019-12-03 Becton, Dickinson And Company Biological fluid separation device
CA3007915A1 (en) 2016-03-09 2017-09-14 Fresenius Kabi Deutschland Gmbh Device for blood container processing
EP3220298A1 (en) 2016-03-14 2017-09-20 Fenwal, Inc. Cell processing system and method with process parameter control
US10251990B2 (en) 2016-04-29 2019-04-09 Fenwal, Inc. System and method for processing, incubating, and/or selecting biological cells
EP3238760B1 (en) 2016-04-29 2019-10-02 Fenwal, Inc. System and method for selecting and culturing cells
US10221385B2 (en) 2016-05-27 2019-03-05 Fenwal, Inc. Cell processing system and method with post-separation cell count control
EP3248627B1 (en) 2016-05-27 2020-02-26 Fenwal, Inc. Systems and methods for priming a fluid circuit
EP3940706A1 (en) * 2016-05-27 2022-01-19 Fenwal, Inc. Cell processing system and method with preliminary process evaluation
EP3469358A1 (en) 2016-06-09 2019-04-17 Becton, Dickinson and Company Biological fluid separation device
US10654000B2 (en) 2016-07-13 2020-05-19 Fenwal, Inc. Cell processing system and method with centralized data management, monitoring and/or control
US11401494B2 (en) 2016-09-14 2022-08-02 Fenwal, Inc. Cell processing system and method with fill options
EP3512577A1 (en) * 2016-09-16 2019-07-24 Fenwal, Inc. Blood separation systems and methods employing centrifugal and spinning membrane separation techniques
US10363355B2 (en) 2016-09-21 2019-07-30 Fenwal, Inc. System and method for platelet removal during mononuclear cell collection
US10729829B2 (en) * 2016-11-11 2020-08-04 Fenwal, Inc. Systems and methods for platelet concentration with a spinning membrane separator
EP3329947B1 (en) 2016-12-01 2021-06-02 Fenwal, Inc. Fill and finish systems and methods
US10274495B2 (en) 2016-12-21 2019-04-30 Fenwal, Inc. System and method for separating cells incorporating magnetic separation
US10682611B2 (en) 2017-02-22 2020-06-16 Fenwal, Inc. System and method for controlling outlet flow of a device for separating cellular suspensions
CN115247129A (en) 2017-02-27 2022-10-28 田边刚士 Cell processing apparatus
CN108732001B (en) * 2017-04-24 2021-03-05 光宝电子(广州)有限公司 Plasma and blood cell separation device and separation method thereof
RU176517U1 (en) * 2017-04-25 2018-01-22 Александр Викторович Хаймин The device for obtaining viable white blood cells
US10758652B2 (en) 2017-05-30 2020-09-01 Haemonetics Corporation System and method for collecting plasma
EP3422354A1 (en) 2017-06-29 2019-01-02 Fenwal, Inc. System and method for authenticating medical device disposable components
EP3461511B1 (en) * 2017-09-29 2022-04-20 Fenwal, Inc. Systems and methods for processing large volumes of biological fluid
EP3470142A1 (en) 2017-10-11 2019-04-17 Orthogen AG Device comprising a first chamber for receiving a body fluid
US11090478B2 (en) 2017-12-21 2021-08-17 Fenwal, Inc. System and method of sterilely connecting fluid pathways
EP3525214A1 (en) 2018-02-09 2019-08-14 Fenwal, Inc. Custom data fields for automated apheresis procedures
CN108441407B (en) * 2018-04-02 2022-05-13 天晴干细胞股份有限公司 Automatic cell purification and cryopreservation device
EP3553498B1 (en) 2018-04-13 2021-06-02 Fenwal, Inc. Optical detection and measurement of hematocrit and free hemoglobin concentration
US10732083B2 (en) 2018-05-07 2020-08-04 Fremon Scientific, Inc. Thawing biological substances
US11191880B2 (en) 2018-05-16 2021-12-07 Fenwal, Inc. Fill and finish systems and methods for small volume processing
US10886022B2 (en) 2018-05-18 2021-01-05 Fenwal, Inc. System and method for authenticating disposable components in extracorporeal photopheresis
EP3578971B1 (en) 2018-06-05 2021-12-15 Fenwal, Inc. Determination of cause of redness in biological fluid
CA3102092A1 (en) * 2018-06-06 2019-12-12 Limula Sa Apparatus and process for the automated manufacturing of genetically engineered cells from biological fluids
WO2020004381A1 (en) * 2018-06-26 2020-01-02 独立行政法人石油天然ガス・金属鉱物資源機構 Separation membrane module
US11911553B2 (en) 2018-07-06 2024-02-27 Fenwal, Inc. Systems and methods for concentrating cells with a syringe and a centrifuge
JP2019022530A (en) * 2018-11-16 2019-02-14 株式会社カネカ Stand for cell separation device installation
US11137344B2 (en) 2018-11-28 2021-10-05 Fenwal, Inc. Optical mixing of fluids
GB2579673A (en) * 2018-12-12 2020-07-01 Haemair Ltd Cell washing apparatus
US11684725B2 (en) 2018-12-19 2023-06-27 Fenwal, Inc. Disposable syringe for use with pneumatic drivers
EP3705146A3 (en) 2019-03-05 2020-11-25 Fenwal, Inc. Collection of mononuclear cells and peripheral blood stem cells
JP7090337B2 (en) * 2019-03-20 2022-06-24 アイ ピース,インコーポレイテッド Cell processing system and cell processing equipment
JP6530874B1 (en) * 2019-03-20 2019-06-12 剛士 田邊 Cell processing system and cell processing apparatus
JP6530577B1 (en) * 2019-03-20 2019-06-12 剛士 田邊 Cell processing system and cell processing apparatus
JP2020156370A (en) * 2019-03-26 2020-10-01 株式会社京都製作所 Cell suspension processing apparatus
JP7297208B2 (en) * 2019-03-26 2023-06-26 株式会社京都製作所 Cell suspension processor
US20220169968A1 (en) * 2019-03-26 2022-06-02 Kyoto Seisakusho Co., Ltd. Cell suspension treatment apparatus
EP4238595A3 (en) 2019-05-23 2023-11-29 Fenwal, Inc. Adjustment of target interface location between separated fluid components in a centrifuge
US11666687B2 (en) 2019-06-06 2023-06-06 Fenwal, Inc. Systems and methods for detecting an empty WB container
RU2710356C1 (en) * 2019-08-01 2019-12-26 Общество с ограниченной ответственностью "Научно-производственное предприятие Биотех-М" Mobile device for gravitational blood separation and method of its application
US11478755B2 (en) 2019-08-15 2022-10-25 Fenwal, Inc. Small volume processing systems and methods
US11957828B2 (en) 2019-09-16 2024-04-16 Fenwal, Inc. Dynamic adjustment of algorithms for separation and collection of blood components
US20210123937A1 (en) 2019-10-24 2021-04-29 Fenwal, Inc. Small volume processing systems and methods with capacitive sensing
US11623034B2 (en) * 2020-01-03 2023-04-11 Fenwal, Inc. System and method to lyse and remove red blood cells from a cell product
EP3885050B1 (en) 2020-03-26 2022-10-05 Alfa Laval Corporate AB A centrifugal separator for separating a liquid mixture
CN111893086B (en) * 2020-06-16 2022-07-19 中国科学院苏州生物医学工程技术研究所 Fetal nucleated red blood cell capture carrier, extraction device and method
EP3974789B1 (en) 2020-09-29 2024-05-01 Fenwal, Inc. System for retaining and weighing variously configured containers
US20220111383A1 (en) 2020-10-14 2022-04-14 Fenwal, Inc. In Vitro Diagnostic Device with Integrated Plasma Separator
EP3995163A1 (en) 2020-11-10 2022-05-11 Fenwal, Inc. Retaining table for fluid processing system
CN112094344B (en) * 2020-11-11 2021-01-29 英科博雅基因科技(天津)有限公司 Method for purifying polyclonal antibody of anti-S1 protein receptor binding domain from blood plasma of COVID-19 rehabilitative patients
US11904281B2 (en) 2021-02-11 2024-02-20 Fenwal, Inc. Spinning membrane separator priming systems and methods
CN112915281B (en) * 2021-03-12 2022-12-16 臻叶生物科技有限公司 Preparation device and method of anticoagulant-free PRP (platelet-Rich plasma) biomembrane
WO2022225800A1 (en) 2021-04-19 2022-10-27 Fenwal, Inc. Blood filtration device
CN113769191B (en) * 2021-08-20 2023-11-07 健帆生物科技集团股份有限公司 Control method, equipment and storage medium of double plasma molecular adsorption system
US20230106739A1 (en) 2021-10-04 2023-04-06 Fenwal, Inc. Detection Of Data Entry Errors For Blood Separation Systems
EP4257162A1 (en) 2022-04-06 2023-10-11 Fenwal, Inc. Systems and methods for implementing different versions of a blood separation procedure
WO2024033325A1 (en) 2022-08-10 2024-02-15 Gea Westfalia Separator Group Gmbh Separating apparatus for separating a suspension
CN117547887B (en) * 2024-01-08 2024-03-22 定襄县君睿金属制品有限公司 Novel high-efficient carbon steel filters device

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5053121A (en) * 1986-08-11 1991-10-01 Baxter International Inc. Blood cell washing systems and methods
US5464534A (en) * 1982-12-13 1995-11-07 William F. McLaughlin Blood fractionation system and method
US5707517A (en) * 1995-11-27 1998-01-13 Membrex, Inc. Immersible rotary disc filtration device
US5738792A (en) * 1984-03-21 1998-04-14 Baxter International Inc. Method for separation of matter from suspension
US5972217A (en) * 1994-10-17 1999-10-26 Baxter International Inc. Blood cell separation devices having a membrane with particular coating
US6416665B1 (en) * 1997-12-09 2002-07-09 Mcgrath Kevin Douglas Filtration apparatus

Family Cites Families (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1258053A (en) 1982-12-13 1989-08-01 Halbert Fischel Blood fractionation system and method
EP0310205B1 (en) 1984-03-21 1994-07-20 McLaughlin, William Francis Filtering a liquid suspension
JPS6125903U (en) * 1984-07-24 1986-02-15 株式会社 伊藤鉄工所 filtration equipment
US4776964A (en) 1984-08-24 1988-10-11 William F. McLaughlin Closed hemapheresis system and method
US4753729A (en) 1985-04-26 1988-06-28 Baxter Travenol Laboratories, Inc. Rotor drive for medical disposables
US4755300A (en) 1985-12-23 1988-07-05 Haemonetics Corporation Couette membrane filtration apparatus for separating suspended components in a fluid medium using high shear
JPS63292964A (en) * 1987-05-26 1988-11-30 Kuraray Co Ltd Plasma treatment apparatus
DE68902698C5 (en) * 1988-06-23 2005-07-14 Asahi Medical Co. Ltd. Method for separating blood into blood components and unit for separating blood components.
JP2838725B2 (en) 1990-05-02 1998-12-16 テルモ株式会社 Blood collection equipment
US5135667A (en) 1990-06-14 1992-08-04 Baxter International Inc. Method and apparatus for administration of anticoagulant to red cell suspension output of a blood separator
JP2953753B2 (en) * 1990-06-28 1999-09-27 テルモ株式会社 Plasma collection device
US5069792A (en) * 1990-07-10 1991-12-03 Baxter International Inc. Adaptive filter flow control system and method
US5178603A (en) * 1990-07-24 1993-01-12 Baxter International, Inc. Blood extraction and reinfusion flow control system and method
US5234608A (en) * 1990-12-11 1993-08-10 Baxter International Inc. Systems and methods for processing cellular rich suspensions
US5254250A (en) 1991-05-30 1993-10-19 Membrex, Inc. Rotary filtration device and filter pack therefor
US5298016A (en) 1992-03-02 1994-03-29 Advanced Haemotechnologies Apparatus for separating plasma and other wastes from blood
JPH05317413A (en) * 1992-05-20 1993-12-03 Asahi Medical Co Ltd Sampler for blood component removed leukocyte
JP3696646B2 (en) * 1995-03-02 2005-09-21 テルモ株式会社 Blood management system
US5762791A (en) 1995-08-09 1998-06-09 Baxter International Inc. Systems for separating high hematocrit red blood cell concentrations
US6251284B1 (en) 1995-08-09 2001-06-26 Baxter International Inc. Systems and methods which obtain a uniform targeted volume of concentrated red blood cells in diverse donor populations
US6527957B1 (en) 1995-08-09 2003-03-04 Baxter International Inc. Methods for separating, collecting and storing red blood cells
TW391881B (en) 1996-09-25 2000-06-01 Baxter Int Method and apparatus for filtering suspensions of medical and biological fluids or the like
US6187198B1 (en) 1997-10-21 2001-02-13 Dsu Medical Corporation Automatic priming of connected blood sets
US5951870A (en) 1997-10-21 1999-09-14 Dsu Medical Corporation Automatic priming of blood sets
RU2123525C1 (en) 1997-11-14 1998-12-20 Общество с ограниченной ответственностью "БИОЛЮКС" Plant for production of biological product
US6251295B1 (en) * 1998-01-08 2001-06-26 Nexell Therapeutics Inc. Method for recirculation washing of blood cells
JP3517359B2 (en) 1998-09-14 2004-04-12 テルモ株式会社 Cell separation / collection apparatus and cell separation / collection method
JP4638986B2 (en) * 1998-10-16 2011-02-23 テルモ メディカル コーポレイション Blood processing equipment
US6294094B1 (en) 1999-09-03 2001-09-25 Baxter International Inc. Systems and methods for sensing red blood cell hematocrit
US6348156B1 (en) 1999-09-03 2002-02-19 Baxter International Inc. Blood processing systems and methods with sensors to detect contamination due to presence of cellular components or dilution due to presence of plasma
US6284142B1 (en) * 1999-09-03 2001-09-04 Baxter International Inc. Sensing systems and methods for differentiating between different cellular blood species during extracorporeal blood separation or processing
US6969367B2 (en) 2000-02-02 2005-11-29 Xepmed, Inc. Extracorporeal pathogen reduction system
US7470245B2 (en) 2000-02-02 2008-12-30 Xepmed, Inc. Extracorporeal pathogen reduction system
US6423023B1 (en) 2000-02-02 2002-07-23 Chang Yu-An Method and apparatus for enhanced plasmapheresis
EP1127606A1 (en) 2000-02-24 2001-08-29 Stichting Energieonderzoek Centrum Nederland(ECN) Membrane module for the separation of fluid mixtures
EP1267990B1 (en) * 2000-03-31 2015-07-29 Fenwal, Inc. Systems and methods for collecting leukocyte-reduced blood components, including plasma that is free or virtually free of cellular blood species
US6471855B1 (en) * 2000-11-22 2002-10-29 Baxter International Inc. Cassette with integral separation device
US6884228B2 (en) * 2001-03-06 2005-04-26 Baxter International Inc. Automated system adaptable for use with different fluid circuits
US20020179544A1 (en) 2001-04-27 2002-12-05 Nexell Therapeutics, Inc. Cell processing and fluid transfer apparatus and method of use
US20030040835A1 (en) 2001-04-28 2003-02-27 Baxter International Inc. A system and method for managing inventory of blood component collection soft goods in a blood component collection facility
US20030018289A1 (en) * 2001-05-24 2003-01-23 Kok-Hwee Ng System and method for interfacing with an operator within a blood collection facility
FR2827176B1 (en) * 2001-07-12 2003-12-19 Biolog METHOD FOR RELIABILITY OF THE TRACEABILITY OF BLOOD SAMPLES DURING EXTRACTION OPERATIONS, IN PARTICULAR PLASMA AND RED CELLS
US20030010717A1 (en) * 2001-07-13 2003-01-16 Nx Stage Medical, Inc. Systems and methods for handling air and/or flushing fluids in a fluid circuit
US6863821B2 (en) 2002-02-02 2005-03-08 Baxter International Inc. Shear-enhanced systems and methods for removing waste materials and liquid from the blood
US7479123B2 (en) 2002-03-04 2009-01-20 Therakos, Inc. Method for collecting a desired blood component and performing a photopheresis treatment
US7211191B2 (en) * 2004-09-30 2007-05-01 Thermogenesis Corp. Blood component separation method and apparatus
CA2485227C (en) 2002-05-30 2009-11-17 Kkj, Inc. Vortex enhanced filtration device and methods
US7189352B2 (en) 2003-01-14 2007-03-13 Medtronic, Inc. Extracorporeal blood circuit priming system and method
DE602004030539D1 (en) 2003-03-10 2011-01-27 Donald W Schoendorfer THROUGH SPINNING IMPROVED FILTER DEVICES
RU2329831C2 (en) 2004-02-09 2008-07-27 Анджелантони Индустрие Спа Device for supply, storage and provision of blood packages
CN2676200Y (en) * 2004-02-23 2005-02-02 上海达华医疗器械有限公司 Blood plasma centrifugal filter separator
US7374677B2 (en) 2004-08-20 2008-05-20 Kkj, Inc. Two stage hemofiltration that generates replacement fluid
JP4822258B2 (en) * 2005-11-11 2011-11-24 日機装株式会社 Hemodialysis machine
JP4466549B2 (en) 2005-12-06 2010-05-26 トヨタ自動車株式会社 Method for producing single-walled carbon nanotubes with increased diameter
JP2008067779A (en) 2006-09-12 2008-03-27 Terumo Corp Blood component collecting apparatus, disposable unit, and mainframe
CA2681912C (en) * 2007-02-27 2015-09-29 Deka Products Limited Partnership Hemodialysis systems and methods
CN101254318B (en) * 2007-02-28 2011-12-07 法哈德·阿赫默德·阿坎哈尔 Portable hematodialysis instrument capable of continuously working
CN102886081A (en) 2007-03-30 2013-01-23 株式会社Jms Blood purification control apparatus
US8444587B2 (en) 2007-10-01 2013-05-21 Baxter International Inc. Fluid and air handling in blood and dialysis circuits
JP5215412B2 (en) * 2007-12-26 2013-06-19 テルモ ビーシーティー、インコーポレーテッド Apparatus for the controlled addition of solvents to blood components
EP2239583B1 (en) * 2008-01-21 2020-12-09 Nexus Dx, Inc. Thin-film layered centrifuge device and analysis method using the same
US8192386B2 (en) 2008-02-27 2012-06-05 Fenwal, Inc. System and method for controlling hematocrit during a therapeutic red blood cell exchange procedure
US20090211962A1 (en) * 2008-02-27 2009-08-27 Kyungyoon Min Processing chambers for use with apheresis devices
JP2009297339A (en) * 2008-06-16 2009-12-24 Nikkiso Co Ltd Blood purifying device and priming method thereof
JP5294985B2 (en) * 2008-12-16 2013-09-18 日機装株式会社 Blood purification apparatus and priming method thereof
RU85099U1 (en) * 2009-03-24 2009-07-27 Юрий Данилович Марцинишин FLOW FILTER OF FLUIDS
JP5642775B2 (en) * 2009-05-27 2014-12-17 パーカー・ハニフィン・コーポレーション How to remove air from the filter
EP2515966B1 (en) * 2009-12-22 2017-03-29 Terumo BCT, Inc. Methods and apparatus for collection of filtered blood components, in particular red blood cells
EP2525898A2 (en) 2010-01-21 2012-11-28 Kkj, Inc. Vortex-enhanced filtration devices
US8920659B2 (en) * 2010-11-08 2014-12-30 New York Blood Center, Inc. Component preparation system
US9381291B2 (en) * 2011-03-11 2016-07-05 Fenwal, Inc. Membrane separation devices, systems and methods employing same and data management systems and methods
US8840790B2 (en) 2011-04-27 2014-09-23 Fenwal, Inc. Systems and methods of controlling fouling during a filtration procedure

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5464534A (en) * 1982-12-13 1995-11-07 William F. McLaughlin Blood fractionation system and method
US5738792A (en) * 1984-03-21 1998-04-14 Baxter International Inc. Method for separation of matter from suspension
US5053121A (en) * 1986-08-11 1991-10-01 Baxter International Inc. Blood cell washing systems and methods
US5972217A (en) * 1994-10-17 1999-10-26 Baxter International Inc. Blood cell separation devices having a membrane with particular coating
US5707517A (en) * 1995-11-27 1998-01-13 Membrex, Inc. Immersible rotary disc filtration device
US6416665B1 (en) * 1997-12-09 2002-07-09 Mcgrath Kevin Douglas Filtration apparatus

Also Published As

Publication number Publication date
RU2591658C2 (en) 2016-07-20
JP6589008B2 (en) 2019-10-09
EP2683469B1 (en) 2017-05-03
CA2825920C (en) 2018-09-04
AU2012229301B2 (en) 2016-08-11
CA2825820A1 (en) 2012-09-20
AU2012229313A1 (en) 2013-09-19
CA2825820C (en) 2023-06-27
RU2013145505A (en) 2015-04-20
US20180303997A1 (en) 2018-10-25
AU2012229301A1 (en) 2013-09-19
EP2683469A1 (en) 2014-01-15
EP2683457B1 (en) 2018-06-20
CN103429308B (en) 2016-02-03
US9408961B2 (en) 2016-08-09
BR112013022800B1 (en) 2020-09-29
US9764075B2 (en) 2017-09-19
BR112013022451A2 (en) 2016-12-06
CN103429323A (en) 2013-12-04
BR112013022656B1 (en) 2021-06-22
RU2601449C2 (en) 2016-11-10
US20130341291A1 (en) 2013-12-26
JP5917574B2 (en) 2016-05-18
CN103415334A (en) 2013-11-27
BR112013022568B1 (en) 2021-01-12
EP2683471A1 (en) 2014-01-15
AU2012229311A1 (en) 2013-09-19
RU2013145567A (en) 2015-04-20
RU2595704C2 (en) 2016-08-27
RU2598455C2 (en) 2016-09-27
AU2012229321B2 (en) 2016-12-08
EP2683455B1 (en) 2017-08-30
EP2683455A4 (en) 2015-04-22
CA2825824C (en) 2018-08-21
EP2683470A1 (en) 2014-01-15
US9656013B2 (en) 2017-05-23
EP2683457A1 (en) 2014-01-15
CN103429309A (en) 2013-12-04
EP3395425B1 (en) 2022-10-12
WO2012125457A1 (en) 2012-09-20
JP5913385B2 (en) 2016-04-27
RU2597140C2 (en) 2016-09-10
BR112013022647B1 (en) 2021-01-12
EP2683456A4 (en) 2015-06-24
CN103429308A (en) 2013-12-04
WO2012125463A1 (en) 2012-09-20
JP2014514028A (en) 2014-06-19
CA2825823C (en) 2018-09-04
US9895482B2 (en) 2018-02-20
JP2014515631A (en) 2014-07-03
CN103415334B (en) 2015-11-25
EP2683471A4 (en) 2015-08-05
BR112013022656A2 (en) 2020-10-13
RU2615536C2 (en) 2017-04-05
CN103429309B (en) 2015-09-09
RU2013145531A (en) 2015-04-20
JP2014515630A (en) 2014-07-03
EP2683457A4 (en) 2015-08-05
CA2825819A1 (en) 2012-09-20
EP2683455A1 (en) 2014-01-15
JP2018134465A (en) 2018-08-30
JP5897612B2 (en) 2016-03-30
AU2012229311B2 (en) 2016-07-21
US20130341274A1 (en) 2013-12-26
EP2683456B1 (en) 2019-01-09
BR112013022599A2 (en) 2016-12-06
CA2825826A1 (en) 2012-09-20
BR112013022800A2 (en) 2016-12-06
CN103429321A (en) 2013-12-04
WO2012125470A1 (en) 2012-09-20
JP6006243B2 (en) 2016-10-12
BR112013022599B1 (en) 2021-01-12
CA2825826C (en) 2021-07-13
US9381291B2 (en) 2016-07-05
AU2012229321A1 (en) 2013-09-19
JP2014514029A (en) 2014-06-19
JP2016190046A (en) 2016-11-10
AU2012229298A1 (en) 2013-09-19
CA2825920A1 (en) 2012-09-20
AU2012229298B2 (en) 2016-07-21
JP5897613B2 (en) 2016-03-30
CN103429323B (en) 2016-08-10
US20140010738A1 (en) 2014-01-09
RU2013145565A (en) 2015-04-20
CA2825823A1 (en) 2012-09-20
EP2683470B1 (en) 2017-05-03
RU2013145564A (en) 2015-04-20
BR112013022451B1 (en) 2021-01-12
EP3395425A1 (en) 2018-10-31
WO2012125460A1 (en) 2012-09-20
CN103415329A (en) 2013-11-27
US20130345674A1 (en) 2013-12-26
EP2683456A1 (en) 2014-01-15
EP2683471B1 (en) 2017-08-02
RU2013145568A (en) 2015-04-20
CA2825819C (en) 2019-10-15
AU2012229313B2 (en) 2016-08-11
AU2012229304A1 (en) 2013-09-19
CA2825824A1 (en) 2012-09-20
CN103415329B (en) 2015-05-13
EP2683470A4 (en) 2015-02-25
WO2012125472A1 (en) 2012-09-20
BR112013022647A2 (en) 2016-12-06
US20130341275A1 (en) 2013-12-26
AU2012229304B2 (en) 2016-08-11
JP2014515629A (en) 2014-07-03
US20130334139A1 (en) 2013-12-19
EP2683469A4 (en) 2015-08-12
BR112013022568A2 (en) 2016-12-06
JP2014509854A (en) 2014-04-24
WO2012125480A1 (en) 2012-09-20

Similar Documents

Publication Publication Date Title
CN103429321B (en) Membrane separation device, the system and method utilizing this device and data management system and method
EP2910259B1 (en) Membrane separation devices
EP3028724B1 (en) Membrane separation and washing devices, systems and methods employing same

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant